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Chapter 1 
General introduction 
 
 
 
 
1.1  Cartilage tissue engineering  
1.1.1  Articular cartilage and defect 
Articular cartilage presents like a white layer on the surface of long bone ends, is the most important 
tissue for movement. Because it can withstand weight-bearing and work as a lubricant to decrease the 
friction between the joints. The cartilage is comprised of dense extracellular matrices while almost no 
vascularity. The extracellular matrix (ECM) of articular cartilage is composed of aggrecan and collagen type 
II, which offer strong mechanical property and smooth surface after assembly into a complex 
three-dimensional (3D) network structure. As shown in Figure 1.1, aggrecan contains core proteins and link 
proteins with abundant glycosaminoglycan (GAG) chains. Due to the heavy pressure or injury during 
strenuous exercise, the cartilage is easily damaged. The defect will lead to inflammation and degeneration of 
the cartilage which induce severe joint pain and unfree mobility. Unfortunately, the self-healing capacity of 
cartilage is very limited due to its lack of vasculature for nutrition supply.[1] 
1.1.2  Traditional treatments and their limitations 
Conservative measures are helpful for the early phase of chronic cartilage defects, such as using the 
anti-inflammatory drug that can calm the inflammatory response.[2] But this kind of the drug may have side 
effects. The purpose of cartilage repair is to restore the healthy joint surface with weight bearing capacity and 
without pain. Surgical treatments are needed if the defect is serious, which include drilling, abrasion 
arthroplasty and microfracture.[3-5] Among these treatments, microfracture is one frequently used method. 
The aim of this surgery is to induce the blood and stem cells from bone marrow to the defected area by 
puncturing the subchondral.[6,7] However, the newly formed cartilage using this method is fibrocartilage 
rather than hyaline cartilage. From composition point, the fibrocartilage contains much less proteoglycan and 
more collagen type I instead of collagen type II than native hyaline cartilage. Therefore, in this fibrocartilage 
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area, the ability of compression withstanding and offering smooth surface decreases over time. Furthermore, 
the repaired cartilage shows bad integration with residual cartilage. 
 
 
Figure 1.1 Structure and ECM of articular cartilage 
 
1.1.3  The principles of cartilage tissue engineering  
To address the challenge of cartilage regeneration, an approach is highly needed to replace the 
traditional treatments. Cartilage tissue engineering has been developed as a promising approach to solve the 
problems of traditional treatments. Cartilage tissue engineering combines cells, scaffolds and bioactive 
molecules to induce the repair and regeneration of cartilage tissue (Figure 1.2). During this process, the 
critical part is scaffold that has the function to create a good microenvironment for cell activities, such as cell 
adhesion, cell proliferation, secretion and assembly of the ECM.  
 
Figure 1.2 Principles of cartilage tissue engineering 
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1.1.4  Cells 
Healthy chondrocytes can be arthroscopically isolated from the non-weight bearing area of the 
cartilage.[8] Chondrocytes obtained through this method is the best source, but usually, the cell number is 
very limited.[9] Chondrocytes can proliferate to a large cell number during in vitro expansion to meet the 
requirements of tissue engineering. However, during the in vitro expansion, chondrocytes are easy to lose the 
chondrogenic phenotype.  
Besides the mature chondrocytes, adult stem cells have been studied a lot for cartilage regeneration. The 
adult stem cells can proliferate and keep the potential for differentiation into other specialized cells. One of 
such kinds of adult stem cells is mesenchymal stem cells, which can be derived from many tissues, such as 
bone marrow, adipose tissue and synovial tissue.[10-12] In the situation of shortage of chondrocytes, these 
stem cells can be used for cartilage tissue regeneration after chondrogenic differentiation. 
1.1.5  Bioactive molecules 
To promote the cell functions and facilitate cartilage tissue regeneration, bioactive molecules, such as 
growth factors are frequently used. In tissue engineering, growth factors are commonly used to promote cell 
proliferation and differentiation. There are several common growth factors for cartilage tissue engineering, 
such as basic fibroblast growth factor (bFGF) and transforming growth factor beta (TGF-β). The former one 
can promote cell proliferation while keep the cell phenotype. TGF-β shows good function for maintenance or 
redifferentiation of chondrocyte phenotype.[13] Furthermore, it also exhibits very effective effects on 
chondrogenic differentiation of stem cells.[14] 
1.1.6  Scaffolds 
In cartilage tissue engineering, scaffolds serve as temporary templates to accommodate cells and 
provide various signals for cell adhesion, proliferation, differentiation and ECM secretion. After all the 
processes, the scaffolds should be degraded to further provide spaces for the final tissue regeneration. During 
the maturation of cell/scaffold construct, the scaffolds should provide suitable biomechanical and 
biochemical stimuli for the cell activities. Based on the principle of tissue engineering and functions of the 
scaffolds, the following requirements are summarized for scaffold designs. 
 
I. Biocompatibility 
This character is the most important property of scaffolds. Compared with artificial prosthesis 
replacements, the advantage of tissue engineering is bioactivity due to the cell-laden characteristic. Therefore, 
materials and methods for scaffolds fabrication should be biocompatible to allow cell attachment, 
proliferation and differentiation.[15] The safety of scaffold degradation products should also be considered. 
The aim of tissue engineering is the application in clinic. The effects of scaffolds on the surrounding tissues 
and inflammatory responses should also be taken into account to make sure the biocompatibility of 
scaffolds.[16] 
 
II. Biodegradability 
The scaffolds-forming materials should be metabolically degradable by the body.[17] The scaffold 
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degradation speed is very important. Quick degradation will affect the integrity of scaffolds and further 
influence the tissue regeneration. But if the degradation is too slow, it will inhibit the new tissue formation. 
Therefore, the proper speed of hydrolytic or enzymatic degradation is necessary for cartilage tissue 
regeneration.[18] 
 
III. Biomechanical property 
Biomechanical property of scaffolds should be designed from two aspects. One is easy operation and 
withstanding deformation. The other is scaffolds should be strong enough to be handled and be stable during 
in vitro culture and in vivo implantation.[19] Especially for cartilage tissue engineering, high mechanical 
property is needed for the weight bearing. Another requirement is the proper mechanical stimulus for the 
encapsulated cells. Because many studies have shown that mechanical stimulus can affect the cell fates.[20]  
 
IV. Biochemical property 
The materials composition and chemical properties are important for cell functions and engineering a 
good 3D tissue. For example, many studies have reported that the surface charge of the matrices can affect 
the differentiation of stem cells.[21] Modification of scaffolds with arginylglycylaspartic acid (RGD) motifs 
has been reported to improve cell viability and activity.[22] 
 
V. Sterilizability 
Scaffolds should be sterilized by a simple way without loss of functions. The sterilization methods 
include filtration (0.22 µm filter), heating, ethylene oxide (EO) gas and ethanol immersing. The methods and 
protocols should be chose depending on the property of scaffolds.[23]  
1.2  Scaffolds for cartilage tissue engineering 
1.2.1  Materials for scaffold fabrication  
a) Synthetic materials 
Synthetic materials, such as PEG, PLGA and PVA are usually used for scaffold fabrication. The 
advantages of these materials are the reproducibility and controllability, which are the result of specific 
molecular weights (MW) and block structures (Figure 1.3).[24] However, the drawback of synthetic 
materials is the limited biological properties, which control the cells and matrices interaction.  
 
I. Poly(ethylene glycol) PEG 
PEG has been approved by FDA for several biomedical applications due to the low toxicity. PEG 
hydrogels have been widely studied as cell-laden scaffolds and drug carriers. It can be modified with acrylate 
or methacrylate to form photocrosslinkable hydrogels.[25] The block copolymer of PEG and PLLA can form 
a thermally reversible hydrogel.[26] PEG hydrogels with high mechanical property have been used to 
encapsulate chondrocytes for cartilage tissue engineering.[27] However, the lack of bioactivity and 
biodegradability of PEG limit the application for long time 3D cell culture. 
  
II. Poly(vinyl alcohol) (PVA) 
PVA has been used for many biomedical applications due to the good biocompatibility. Physically 
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crosslinked PVA hydrogels can be formed by several freezing and thawing cycles. However, the critical 
disadvantage of PVA is nonsupport of cell adhesion, which causes the seldom usage for 3D cell culture.[28]  
 
III. Poly(lactic acid-co-glycolic acid) (PLGA) 
PLGA is the copolymer of glycolic acid and lactic acid. PLGA has been frequently used for pre-made 
porous scaffold preparation as it has good biodegradability, biocompatibility and excellent mechanical 
property. The biodegradability can be controlled by the ratio of glycolic acid and lactic acid.[29] However, 
PLGA is difficult to be dissolved in aqueous solution, which limits the usage for hydrogel fabrication. 
 
Figure 1.3 The chemical structure of PEG, PVA and PLGA. 
 
b) Natural materials 
Natural materials have drawn more attention in tissue engineering compared with synthetic materials 
because of their good biocompatibility and bioactivity.[30] The sources of these biopolymers are extensive, 
such as humans, animals, plants and bacteria. The protein-based materials like collagen and fibrin exhibit 
good biocompatibility and enzyme-degradable property, which are the main components of mammalian 
tissue ECM.[31]. The other native polymers include hyaluronic acid, chondroitin sulfate, alginate and 
chitosan.[32-34] The structures, functions and applications of these natural materials are summarized below. 
 
I. Hyaluronic acid (HA) 
HA as a glycosaminoglycan is commonly prevalent in body liquid, such as the synovial fluid in joints 
and various tissue ECM. However, the commonly used HA is produced from bacteria rather than animals due 
to the productivity and cost.[35] Fermentation method can eliminate the possibility of disease transfer.[36] 
The biological functions of HA include lubrication, enhance the mechanical property of tissue and control 
the cell behaviors. The super high molecular weight of HA allows it to maintain the elastoviscosity of joint 
synovial and eye vitreous fluid. HA also plays a significant role in the assembly of proteoglycan in the 
cartilage ECM, which is important for the lubrication function of connecting tissue. Many of cell behaviors, 
such as migration, differentiation and inflammation are affected by the bonding between HA and cell surface 
receptors including CD44, ICAM-1 and RHAMM. It has been reported HA can bond chondrocytes through 
CD44 receptor and promote the redifferentiation of dedifferentiated chondrocytes.[37] HA has also been 
used for the wound healing. The wound contraction and re-epithelialization can be enhanced by more 
bonding of RHAMM with HA scaffolds.[38] The adhesion molecule (ICAM) is widely distributed on the 
surface of endothelial and macrophages. Chen et al. have reported that the ICAM-1 binding to HA-based 
scaffolds may control the inflammation activation.[39] The structure of HA is repeated disaccharides with 
β-D-glucuronic acid and N-acetyl-β-D-glucosamine units (Figure 1.4). Therefore, the functional groups 
(carboxyl and hydroxyl) can be used to crosslink with other bioactive molecules. For example, the 
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HA-collagen scaffolds have been prepared by using EDC/NHS crosslinking. The mechanical property and 
chondrogenic functions have been studied.[8,40] After inducing photoreactive groups by modification with 
glycidyl methacrylate, HA derivative can be crosslinked to form photocrosslinkable hydrogels for tissue 
engineering.[41] 
 
II. Chondroitin sulfate (CS) 
CS is sulfated glycosaminoglycan with a linear structure existing in cartilage tissue ECM. It is 
composed of disaccharide (N-acetylgalactosamine and glucuronic acid) and attached to proteins to form 
proteoglycan that is important for cartilage functions.[42] The location of sulfate groups classifies the CS as 
chondroitin-4-sulfate and chondroitin-6-sulfate. It is reported that CS in cartilage ECM provides the ability to 
resist the compression. It has also been shown that CS can promote GAG synthesis and chondrocyte 
proliferation.[43] ECM mimicking scaffolds can be prepared by adding CS. Chondrocytes cultured in such 
kind of scaffolds have round morphology, enhanced gene expression and secretion of cartilaginous 
ECM.[44] CS and HA are the main component of GAG in cartilage. Addition of HA/CS in scaffolds is useful 
for chondrogenesis. 
 
III. Alginate 
Alginate is an anionic biopolymer obtaining from bacteria and brown seaweed.[32,45] Alginate is 
comprised by (1–4)-linked β-D-mannuronicacid (M) and α-L-guluronic acid (G) monomers. The ratio of these 
monomers is depending on the various sources.[46] Because of its biocompatibility, low toxicity and cost, 
more importantly, the mild crosslinking method by divalent ions, alginate has been used for many biomedical 
applications including drug delivery and cell transplantation. For example, alginate hydrogel crosslinked by 
adding calcium sulfate can be used to encapsulate chondrocytes. The hydrogels have been reported to 
enhance secretion of chondrogenic ECM and increase of mechanical property.[47] The mechanism of ion 
crosslinking is the divalent cations, such as Ca2+ binding with G monomers. Therefore, the composition ratio 
and molecular weight are the main factors to affect the physical properties of alginate hydrogels.[48] 
Although alginate has good biocompatibility, it also has been reported that immunogenic response exists in 
high M content alginate and unpurified alginate.[49] This ionically crosslinked alginate scaffold undergoes 
uncontrolled dissolution due to the ion exchange in vitro and in vivo.[50] After dissolution, the molecular 
weight of alginate is still higher than the clearance threshold of the kidneys. There is no enzyme to degrade 
alginate in vivo. Therefore, it is likely the alginate cannot be removed from our body completely.[51]  
 
IV. Chitosan 
Chitosan is linear polysaccharides derived from chitin that is abundant in some plants or animals, such 
as crabs and shrimps. The deacetylation treatment can produce chitosan from chitin and change the 
crystallinity of the polymers. The stable and crystalline structure makes chitosan insoluble in physiological 
solutions. The free amino groups in chitosan are protonated in an acidic environment, which makes chitosan 
soluble.[33] The chemical structure is repeated (1–4)-linked D-glucosamine and N-acetyl-D-glucosamine. 
Because chitosan is structurally similar to GAG and can be degradable by the enzymes in the body, it has 
been studied for many kinds of tissue engineering applications. But the unsolvable property in neutral 
aqueous solution limits the applications for the 3D cell encapsulation.[33] Many studies have used the 
cationic nature of chitosan for biomedical applications. This charge density allows chitosan to form complex 
coacervates with anionic polymers, such as alginate and insoluble ionic complexes with ions, such as 
Fe.[52,53] 
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Figure 1.4 The chemical structure of HA, CS, Alginic acid and Chitosan. (CS: R1, R2, R3 = H or SO3H.) 
 
V. Collagen  
Collagen is attractive for fabrication of scaffolds because it is the main ECM component of various 
tissues and the most abundant protein.[54] There are many types of collagen depending on the different 
spatial structure which is formed by three collagen chain rope together.[31] This helix structure of collagen 
can further assemble into fibrils by hydrogen bonding, which can be packed closely to form collagen 
fibers.[55] Compared with other biopolymers, collagen can be degraded by many kinds of enzymes 
including metalloproteases, collagenase and serine proteases.[56] This property allows the collagen scaffolds 
to be replaced with the secreted native ECM after long-term implantation. Collagen scaffolds have been 
developed with different structures and properties for biomedical applications. It has been reported that 
collagen scaffolds with interconnected porous structures can be fabricated by mixing with ice particles. 
These collagen scaffolds show excellent biocompatibility and functions for various kinds of tissue 
regeneration, such as skin, cartilage and bone.[57,58] 
 
VI. Gelatin 
Collagen has many advantages for tissue engineering. However, collagen contains some antigens which 
may induce immunogenicity when implanted in vivo.[59] In order to eliminate the collagen potential 
immunogenicity, gelatin as a substitute is widely used for scaffold fabrication. Except thermal treatment, 
gelatin can be derived from collagen by acidic (type A) or alkaline treatments (type B) to degrade the helix 
structures of collagen into the single chain by hydrolysis.[60] Luckily, after the treatment, gelatin shows 
almost no immunogenicity while still keeping many advantages of collagen. For example, gelatin polymer 
chain keeps the cell adhesion peptides and metalloproteinase degradable peptides. The tripeptide sequence 
RGD promotes the cell adhesion that is important for cell viability and proliferation.[61] The degradable 
sequence is related to the biodegradability of scaffolds and affects the cell-matrices interaction. The other 
attractive point of gelatin as biomaterial is the low cost and easy availability from many animals like pigs 
and cows. Gelatin can be easily modified and used to fabricate porous scaffolds and hydrogels for the 
regeneration of damaged tissues.[62] The previous results have demonstrated the good functions on the 
cultivation of different cell types and tissue regenerations.[63,64]  
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VII. Fibrin 
Fibrin is a biopolymer consisted of fibrinogen. The fibrinogen molecule has two sets of three 
polypeptide chains that are bonded together by six disulfide bridges.[65] Fibrin monomer is formed after 
treatment by thrombin and has the tendency to assemble into insoluble fibrin. In vivo, the blood coagulation 
factor XIIIa works as a transglutaminase which crosslinks γ chains in the fibrin polymer by introducing 
intermolecular bonds between the lysine of γ chain and glutamine of the other.[66] After crosslinking, the 
fibrin network cannot be degraded by protease easily.[67] To fabricate tissue engineering scaffolds, fibrin 
network can be built by using chemical crosslinkers, such as genipin.[68] Fibrin hydrogel crosslinked by 
chemical crosslinker is not suitable for cell encapsulation due to the cytotoxicity. Fibrin hydrogel crosslinked 
by thrombin usually cannot be injected and has low mechanical properties.[69] 
 
VIII. Silk fibroin 
Silk fibroin is another protein based biopolymer for tissue engineering. It can be obtained by the 
treatment of silk fibers produced by silkworms and spiders.[70] The purpose of the treatment for the cocoon 
silk is to remove the sericin protein coated on the surface of silk fibroin core protein, which may cause 
immune responses. Silk fibroin exhibits strong mechanical property and good biocompatibility which make 
the silk fibroin as a suitable candidate for tissue engineering. Silk fibroin has also been developed as a 
potential matrix for drug releases, such as insulin-like growth factor I and surface coating.[71,72] Usually, 
the beta-sheet structure formation will make the fibroin insoluble, which works as physical crosslinking. For 
example, silk fibroin can be treated with methanol after freeze-drying to form porous structure and to obtain 
stable porous scaffold in aqueous solution.[73] Some treatments including vortex and sonication can induce 
silk fibroin aqueous solution to form hydrogels quickly.[74,75] However, these methods are not suitable for 
cell encapsulation because the crosslinking environments are unfriendly for the cells.[76] 
1.2.2  Methods for scaffold fabrication  
The functions of scaffolds depend on the materials properties and the structures of scaffolds. Scaffolds 
can be categorized into (a) porous sponges, (b) fabric scaffolds and (c) hydrogels according to the structures 
(Figure 1.5).  
 
a) Porous scaffolds 
The critical abilities of scaffolds are promoting cell adhesion and providing space for proliferation of the 
accommodated cells. There are many methods to form porous structures, such as gas forming, phase 
separation and leaching of porogen including sodium chloride, paraffin and ice particles.[77-81] Among the 
various porogen, the ice particles can induce formation of porous structures with homogeneous distribution 
and good interconnectivity. The pore structures can enhance the nutrient and metabolic waste exchange and 
promote tissue regeneration in the inner part of scaffolds.[58] 
 
b) Fabric scaffolds 
Fabric scaffolds possess high surface area and interconnected structures, which make them attractive for 
tissue engineering. The methods for fabrication of fabric scaffolds include electrospinning, self-assembly, 
phase separation and other techniques.[82-85] The limitation of this method is its low efficiency and 
difficulty to increase the thickness while keeping the good porous structures. 
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c) Hydrogels 
Hydrogels are physically or chemically crosslinked polymer networks that absorb plenty of water and 
swell in aqueous solution. Hydrogels have many advantages because they can provide a three-dimensional 
microenvironment by encapsulation of transplanted cells in the hydrogel matrices and can be delivered to 
defects by low-invasive injection. In hydrogels, transplanted cells are encapsulated in the hydrogel matrices 
that can provide similar in vivo microenvironments for cell differentiation and maintenance of 
phenotype.[86-89] The obvious differences of hydrogels compared with porous sponges and fabric scaffolds 
are the sterilization and cell seeding method. The precursor solution of hydrogels can be sterilized by 
filtration before gelation. And due to the sol-gel translation, cells can be encapsulated in precursor solutions 
before injection and gelation. These advantages make hydrogel more attractive for cartilage tissue 
engineering. 
 
Figure 1.5 Typical methods for scaffolds fabrication. (A) Electrospinning for fabric scaffold. (B) Porogen 
leaching for porous scaffold. (C) Sol-gel crosslinking for hydrogel. 
 
Hydrogels with microporous structures have drawn a lot of attention recently. Compared with bulk 
matrices structure, the microporous structure has the functions of promoting nutrient diffusion and providing 
space for cell spreading and proliferation. The fabrication methods for microporous structure include 3D 
printing, gas forming and porogen leaching. 3D printing can form hydrogel with complex structures. It has 
the ability to control the porosity, internal architecture and curved channels.[90] However, the hydrogel made 
by 3D printing cannot be injected which is important for cartilage tissue engineering. What’s more, the 
high-cost of this method also limits the applications. The gas forming method is used to fabricate porous 
scaffolds and porous hydrogel.[91,92] However, the process conditions are not suitable for cell encapsulation. 
The frequently used methods for microporous hydrogel formation are using leachable porogen. After mixing 
with precursor solution and gelation, the porogen can be dissolved and leached after certain stimuli, such as 
EDTA for calcium crosslinked alginate microbeads and high temperature for physically crosslinked gelatin 
microparticles.[93,94] The leaching of gelatin physically crosslinked microparticles is biocompatible and 
friendly for in vivo applications. However, these gelatin microparticles cannot be used for cell laden, because 
the water/oil emulsion fabrication and sterilization processes make this method difficult for cell laden 
applications. Therefore, a new mild strategy for cell laden gelatin microgel fabrication is needed for 
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microporous hydrogel formation. 
1.3  Crosslinking methods for hydrogels 
1.3.1  Various crosslinking methods 
a) Physically crosslinked hydrogels 
Physically crosslinked hydrogels can be prepared at very mild conditions without using crosslinking 
agents that normally exhibit toxicity to cells or may affect the activity of bioactive molecules encapsulated in 
hydrogels.[95] There are many fabrication methods to prepare physically crosslinked hydrogels, such as 
ionic interactions and self-assembly (Figure 1.6). 
 
I. Ionic crosslinking 
The most representative hydrogels formed by ionic crosslinking is alginate hydrogel. The residues of 
mannuronic acid and glucuronic acid can be cross-linked by calcium ions.[96] This crosslinking method is 
frequently used to encapsulate cells and drugs due to the mild crosslinking environments (at room 
temperature and physiological pH).[97,98] Besides alginate, chitosan can also be crosslinked to form 
hydrogels by glycerol phosphate disodium salt.[99] Moreover, the sol-gel translation of this chitosan 
hydrogel can be adjusted to around 37 oC by increasing its deacetylation degree. Recently, one new ionic 
crosslinking method inspired by the mussel byssus adhesiveness has been used for biomedical 
applications.[100] The crosslinking site is formed by the bonding of catechol group and trivalent iron.[101] 
In addition to metallic ions crosslinking, hydrogel can be formed by complexation between polyanions, such 
as chitosan and polycations, such as dextran sulfate.[102] However, the ionically crosslinked hydrogels are 
usually unstable due to the exchange of ions in vivo.[103,104]  
 
II. Self-assembly  
Self-assembly protein-based hydrogels usually are physically crosslinked by the formation of triple 
helix structure and β-sheet structure. The mechanism involves hydrogen bonding and hydrophobic 
integration. During the crosslinking process, the polymers in aqueous solutions are assembled to form 
relatively stable crosslinking to become hydrogels. For example, collagen aqueous solution can form 
collagen hydrogel at neutral pH and 37 oC. The helix structure of collagen chain can assemble into nanofiber 
and be crosslinked together due to the increase of temperature at neutral pH.[105] The β-sheet rich structure 
of silk fibroin can work as the crosslinkage to inhibit the dissolution of polymer chains. Vortex or sonication 
can also be used to physically crosslink the silk fibroin to make hydrogels.[106] 
Crystallization, the interaction between amphiphilic block and hydrogen bonding can also form 
physically crosslinked hydrogels. Poly(vinyl alcohol) (PVA) is a water soluble polymer that can be 
crosslinked by several freeze-thawing treatments. The PVA crystallites act as crosslinking sites in the 3D 
network.[107] However, this kind of PVA hydrogel can be used as the drug release hydrogel by loading BSA 
or other proteins,[108] rather than 3D cell culture. The amphiphilic block polymers can form hydrogels due 
to the self-assembly of hydrophobic parts of the polymers. For example, after hydrophobic modification, 
dextran, chitosan and other polysaccharides can form physically crosslinked hydrogels.[109,110] Hydrogen 
bonding can induce polyacrylic acid and polyethylene glycol to form a hydrogel, which usually is dependent 
on the pH.[111] Physical crosslinked gelatin hydrogel at a low temperature is also the result of hydrogen 
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bonding formation.[112] 
Although the physically crosslinked methods normally have low toxicity, the fatal drawback of these 
non-covalently crosslinked hydrogels is unstable during in vitro cell culture or in vivo implantation. The 
mechanical support functions of scaffolds will lose if the crosslinking structures are not stable.[113]  
 
b) Chemically crosslinked hydrogels 
Chemically crosslinked hydrogels exhibit better mechanical property and stability compared with 
physically crosslinked hydrogels. There are many methods to prepare the chemically crosslinked hydrogels 
(Figure 1.6).  
 
I. Crosslinking by complementary groups 
Hydrogel-forming water-soluble polymers have many functional groups, such as OH, COOH and NH2. 
The 3D network can be established by covalent bonding between these functional groups by Schiff base 
reaction or using glutaraldehyde and EDC/NHS.[114-116] But these chemical crosslinkers are cytotoxic to 
encapsulated cells.  
 
II. Photopolymerization 
Photopolymerization is a biocompatible crosslinking method to prepare hydrogels. This method has 
been widely used for hydrogel fabrications. The polymer materials are modified with photoreactive moieties, 
such as methacrylate or acrylate groups. The photoreactive polymer solution with photoinitiator can be 
crosslinked under UV light. The photoinitiators can generate free radicals that are transferred to the 
photoreactive carbon double bond groups in the modified polymers to start chain polymerization. This 
method is widely used because many biopolymers can be modified and a variety of cell types can be 
incorporated into the hydrogels.[117] Moreover, the gelation process can be controlled temporally and 
spatially, which means the hydrogels can be injected and polymerized in situ to fill the irregular cartilage 
defects. Therefore, this crosslinking method is ideal for cartilage tissue regeneration. 
 
 
Figure 1.6 Illustration of hydrogel crosslinking mechanism. (A) Ionic crosslinking, (B) Self-assembly, (C) 
Chemical Crosslinking by complementary groups and (D) Photopolymerization. 
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1.3.2  Mechanism of photopolymerization 
Photopolymerization exhibits many advantages, such as injectability, quick gelation and easy 
incorporation with cells and other chemistries. However, there is a limitation of this method. During 
crosslinking the free radicals will be generated. Free radicals can attack cell membrane to induce cell death. 
However, this effect is dosage dependent. Studies have reported that mild condition of photocrosslinking is 
biocompatible, which can be realized easily by decreasing the light energy and amount of 
photoinitiator.[118,119] It has also been reported that high density of methacrylate groups can protect 
encapsulated cells.[120] This section summarizes all the factors involved in the process of 
photopolymerization.  
 
a) Photocrosslinkable polymers 
Photocrosslinking method includes introduction of photoreactive vinyl groups in the polymer, and 
exposure to UV light with the presence of photoinitiators. Synthetic material like PEG and many kinds of 
natural polymers have been studied to fabricate the hydrogels by photopolymerization. Poly (ethylene 
glycol) diacrylate (PEGDA) has been synthesized by the modification with acryloyl chloride under the 
nitrogen environments.[121] However, PEGDA hydrogel is cell nonadhesive and not able to absorb proteins. 
And due to the non-degradability, PEGDA hydrogel usually works as a nondegradable control in short-term 
in vitro cell culture. HA is the commonly used polymer for cartilage tissue engineering. Photoreactive HA 
(HAMA) can be obtained by the modification with glycidyl methacrylate.[122] The previous studies have 
shown that HAMA hydrogel can promote the maintenance of the chondrogenic phenotype of chondrocytes, 
chondrogenic differentiation of MSC and secretion of cartilaginous matrices both in vitro and in 
vivo.[123,124]. Similarly, chondroitin sulfate and chitosan can also be grafted with vinyl groups by reaction 
with glycidyl methacrylate for photopolymerization.[125] The other modification method is to react the 
amino groups in polymers with methacrylic acid. Gelatin methacrylate macromer is usually prepared by this 
method, which can be very easily conducted in a neutral aqueous solution.[126] In this dissertation, gelatin 
methacrylate (GelMA) was used due to the easy modification method and the good biocompatibility of this 
macromer.[127] Furthermore, it is suitable to study the cell-matrix interaction due to the bioactive motifs, 
such as RGD in the polymer chains.   
 
b) Photoinitiators 
There are many kinds of photoinitiators for polymerizing hydrogels, such as 2-hydroxy-1-[4-(hydroxy 
ethoxy)phenyl]-2-methyl-1-propanone(I2959), 1-hydroxycyclohexyl phenyl ketone (HPK) and 
2,2-dimethoxy-2-phenylacetophenone (I651).[128] The initiator as a small molecular, before or after UV 
exposure, can be uptaken by cells. William et al. have compared the toxicity of I2959, HPK and I651 
photoinitiators. The results have shown that even without UV exposure, the molecules with high 
concentration can affect the cell viability by WST-1 assay. I2959 has less toxicity compared with HPK and 
I651. Cultivation of cells with 0.1% I2959 shows almost no effects on bovine chondrocytes viability, but 
80% cell survival for human fetal osteoblasts. I2959 can maintain high cell survival even after 7 minutes 
exposure to UV light. The reason of the toxicity of initiators is thought partly due to the hydrophobicity of 
the molecule.[129] Hydrophobicity can increase the permeability through phospholipid bilayers of cellular 
membranes. The concentration of photoinitiators should be controlled in a way that the generated heating and 
free radicals will not show toxicity to cells and surrounding tissues.[130] In this study, I2959 was used as the 
photoinitiator due to the low cytotoxicity. 
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c) UV energy 
UV irradiation conditions should be optimized because UV light may affect cell viability.[131] UV 
intensity can be controlled by setting the UV energy density of the UV crosslinker machine or by adjusting 
the UV exposure time when the fixed power machine is used.[132] The UV irradiation conditions can also 
affect the polymerization degree.[133]  
 
d) Free radicals 
Photoinitiator can generate free radicals once exposure to UV light. The free radicals can trigger the 
radical polymerization of methacrylate modified polymers. At the same time, free radical can attack the cells 
to break cell membrane and induce generation of intracellular reactive oxygen species. The reactive oxygen 
species can damage proteins and DNA.[134] Therefore, cells may die if the reactive oxygen species 
increases to a certain level.[135] Although this potential drawback exists in photopolymerization system, the 
toxicity can be adjusted by changing the concentration of photoinitiator or the exposure UV energy. For 
example, Bryant et al. have shown that using I2959 activation by 365 nm UV light can be well tolerated by 
fibroblast and chondrocyte.[118] Poly(ethylene glycol) hydrogel polymerized by this system has been used 
for the 3D culture of chondrocytes, osteoblasts, mesenchymal and embryonic stem cells.[86,136-138] 
Therefore, the negative effects of free radicals are tolerable if the amount of photoinitiator and UV exposure 
energy are well controlled. 
1.4  The effect of hydrogel properties on chondrocyte functions 
The challenges for cartilage tissue engineering include the proliferation of cells, maintenance of 
chondrogenic phenotype and mechanical property of the engineered constructs.[139] Hydrogel is 3D 
crosslinked polymer network with abundant water absorption, which is an ideal cell carrier due to the 
biomimetic microenvironment. The biomechanical and biochemical properties of hydrogel, the crosslinking 
density of hydrogel matrices and the microporous structure of hydrogels can affect cell functions. 
Chondrocytes may lose chondrogenic phenotype during 2D cell expansion culture. Therefore, many studies 
have employed growth factors or cell condensation culture to restore the chondrogenic function of 
dedifferentiated chondrocytes.  
1.4.1  The effect of biomechanical property of hydrogel  
It has been reported that the stiffness of 2D surface affects the differentiation direction of MSC.[20] 
Low stiffness promotes the adipogenic differentiation, while high stiffness is beneficial for osteogenesis. Not 
only the stiffness of matrices, stress relaxation of hydrogel matrices also has some effects on osteogenic and 
adipogenic differentiation.[140] Quick relaxation promotes the osteogenesis while slow relaxation is 
beneficial for adipogenesis.[141] Because of the importance of the biomechanical property of hydrogels, 
many literatures have reported the influence of matrix stiffness on the chondrogenic phenotype. For example, 
PEG hydrogels with different compressive moduli have been fabricated by the various concentration of 
macromers and used for chondrocytes culture.[142] HA hydrogels and alginate hydrogels with gradient 
Young’s modulus have also been prepared by changing the macromer concentration.[143,144] Chondrocytes 
can response to the stiffness of the matrices by mechano-transductive pathways and show different behaviors. 
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Besides stiffness, degradation property and crosslinking density can also affect chondrocyte functions. 
1.4.2  The effect of biochemical property of hydrogel  
Besides the biomechanical property, chemical composition of hydrogel precursors can highly affect the 
cell behaviors including viability, adhesion, proliferation and differentiation. For example, the hydrophobic 
and hydrophilic property, charge of environment and cell active motifs are dependent on the biochemical 
property of hydrogels. Synthetic polymer formed hydrogels usually have a hydrophobic property which 
inhibits the cell attachment and other activities. The native ECM of normal tissue is comprised of collagen, 
laminin, fibronectin and aggrecan. The ECM provides favorable biochemical stimuli, such as RGD for 
certain cell functions. The adhesion sites like RGD tripeptide and the receptors on cell membrane constitute 
the whole recognition system for cell adhesion, migration, proliferation and differentiation.[145] Therefore, 
RGD peptides sequence is very important for cell activity. It has been demonstrated that RGD can promote 
the survival of MSC in PEG hydrogels and induce the chondrogenic differentiation.[22] RGD ligands have 
also been reported to increase the chondrogenic gene expression when the matrices are loaded with dynamic 
mechanical force.[146] The results indicate the RGD ligands are necessary for cell-matrix interactions.[136] 
Moreover, different RGD density can affect the redifferentiation of chondrocytes.[147] For chondrocyte 
culture, HA can bond to the CD 44 receptor on cell membrane to affect both chondrocyte survival pathway 
and apoptotic pathway.[148] Therefore, the biochemical property of hydrogel is critical for cell activities and 
functions. 
1.4.3  The effect of pore structure of hydrogel 
The structure of bulk hydrogels is dense polymers with absorbed water and nano-size pores within the 
network.[149] These porous structures allow the exchange of nutrition and waste. However, these pores are 
too small to promote cell proliferation and ECM diffusion. This is the main reason that microporous 
scaffolds are required to offer better nutrition supply and to promote cell proliferation.[150] Collagen 
sponges with open and interconnective microporous structure have been prepared by mixing with ice 
particles.[151] The effects of different pore structure and pore size have been studied for cell culture and 
tissue engineering.[58,63] Hydrogels and porous scaffolds have been compared for culture of 
chondrocytes.[152] Chondrocytes exhibit different morphology, chondrogenesis gene expression and 
production of ECM in hydrogels and porous scaffolds. Proliferation and collagen type I gene expression are 
enhanced but the aggrecan gene expression is down-regulated in sponge scaffolds.[152] However, the porous 
scaffold has shown better functions on chondrogenic differentiation of MSC due to cell aggregation after 
proliferation and improved cell-cell interaction.[153] Many researchers have combined the microporous 
structure of pre-made 3D scaffolds with injectable hydrogels to prepare microporous hydrogels.[154,155] 
They believe the microporous structure should be good for nutrition diffusion and can provide space for cell 
proliferation. For example, physically crosslinked gelatin microbeads have been fabricated and encapsulated 
in alginate hydrogels for cartilage tissue engineering.[156] The results indicate the microporous structures 
promote cell proliferation and up-regulate gene expression of chondrocytes.[157] However, during the 
gradually dissolution and diffusion of porogen materials, different porogen materials and bulk gel materials 
will result in different microenvironments in the micropores and bulk hydrogels. To elucidate the effect of 
microstructures, the same porogen materials and bulk hydrogel matrices are desirable to eliminate the effect 
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from the material difference.  
1.5  Motivation, objectives and outline 
1.5.1 Motivation and objectives 
The biomechanical and biochemical properties of hydrogels affect the cell behaviors, such as 
attachment, migration, proliferation and differentiation. Stiffness as an important biomechanical factor has 
some effects on stem cell differentiation and the maintenance of chondrocyte phenotype. In order to promote 
the chondrogenesis of chondrocytes encapsulated in hydrogels, the properties of hydrogels should be studied 
and optimized to meet the requirement of an ideal scaffold and to offer the best environment for the 
chondrocytes. There are several studies to explore the influence of stiffness on chondrocytes functions. The 
materials used for hydrogels include PEG, agarose and HA. These designs cannot mimic the 
microenvironment of native cartilage. Firstly, the concentration is different which may affect the nutrition 
diffusions and mesh density around the chondrocytes. Secondly, the materials used in previous studies do not 
possess the RGD motifs that are important to control cell functions and to translate mechanical stimulus to 
cells. For example, synthetic polymers, such as PEG shows better influence on chondrocytes after 
modification with RGD motifs.[136] On the other hand, gelatin based hydrogels contain RGD motifs and can 
maintain high cell viability and activity due to their bioactivity. Therefore, biopolymers with RGD sequence 
should be used to prepare the hydrogels. It is meaningful to study the influence of hydrogel stiffness while 
excluding the other factors like mass concentrations and RGD density. To reach such purpose, the hydrogels 
with different stiffness while same RGD density should be used. In this study, the same gelatin concentration 
will be used to prepare the gelatin methacrylate hydrogels. Different stiffness will be achieved by changing 
the degree of methacrylate while keeping gelatin concentration at the same level. 
Gelatin based hydrogels are suitable to mimic the microenvironment of native ECM. But the 
degradation speed and mechanical properties limit the clinical applications, especially for long-term 
implantation. Several methods have been used to improve the mechanical properties, such as increasing the 
crosslinker density or the concentration of precursor solutions. These approaches may affect cell viability 
due to the crosslinker toxicity and the viscosity of solutions. For injectable hydrogels, the high viscosity 
solution will hurt cells by high shear forces during mixing and injections, at the same time, increase the 
difficulty for operations.[158] An effective way is desirable to increase the mechanical property, to prolong 
the degradation time and to decrease the viscosity of the precursor solution. In this study, the double 
methacrylate modified gelatin will be used to solve these limitations. This macromer has a high amount of 
photoreactive vinyl groups allowing the high crosslinking degree which should improve the mechanical 
property and degradation profiles. Furthermore, the second modification can decrease the viscosity of the 
solution by decreasing the hydrogen bonding. By using the GelMA and GelMAGMA hydrogels, the 
influence of crosslinking density on chondrocytes proliferation and phenotype will be investigated. 
Although gelatin hydrogels have shown excellent effects on chondrocyte functions, such as promoting 
the chondrogenic gene expression and chondrogenic ECM secretion, cell proliferation in hydrogel is 
hampered. Moreover, the assembly of secreted ECM is inhibited by the crosslinked polymer network. Porous 
structure of scaffold has been reported to promote cell proliferation by providing the space and enhancing 
nutrition diffusion. Introduction of microporous structures in hydrogels to make microporous gelatin 
hydrogels is an effective strategy to solve the problems. In this study, a useful method to prepare 
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microporous gelatin hydrogels will be proposed. The microporous gelatin hydrogels will be used for 3D 
culture of chondrocytes and comparison with gelatin hydrogels without microporous structures. 
1.5.2 Outline 
In this study, gelatin hydrogels with different degrees of methacrylation, mechanical properties and 
microporous structures will be prepared for chondrocyte culture and cartilage regeneration to explore the 
influence of biomechanical properties and microporous structures on chondrocytes functions.  
 
 
Figure 1.7 Preparation scheme of cell-laden gelatin hydrogels by photopolymerization and 3D culture of 
chondrocytes in vitro and in vivo. 
 
In chapter 2, GelMA hydrogels with various stiffness were fabricated by using macromer with different 
modification degrees. The same concentration of gelatin was used to exclude the effects of biochemical, such 
as RGD density. To test the stiffness of local matrices accurately, atomic force microscope (AFM) was used 
to measure the stiffness. After two weeks culture, the morphology, gene expression and ECM secretion of 
chondrocytes encapsulated in different stiffness hydrogels were compared. 
In chapter 3, glycidyl methacrylate was used to double modify the GelMA macromer with high 
functionalization degree. The mechanical properties including storage modulus and degradation were studied. 
The influence of crosslinking density on chondrocyte proliferation and phenotype was compared by using 
GelMA and GelMAGMA hydrogels.  
In chapter 4, physical crosslinked gelatin microgels with cubic shapes were prepared by mesh-cutting 
method. These microcubes were mixed in GelMAGMA macromer solution before UV crosslinking. The 
microcubes were dissolved to induce microcavities after in vitro culture at 37 oC or in vivo implantation. 
Cell-laden GelMAGMA bulk hydrogel, cell-laden GelMAGMA bulk hydrogel with pure gelatin microcubes 
and GelMAGMA bulk hydrogel with cell-laden gelatin microcubes were designed and studied in vitro and in 
vivo environments to investigate the effect of microporous structures on cell functions.  
In chapter 5, the conclusions and prospects of this dissertation are summarized. 
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Chapter 2 
 
 
Preparation of gelatin methacrylate hydrogels with different 
stiffness for chondrocytes 3D culture 
 
 
 
 
2.1 Summary 
Gelatin hydrogels can mimic the microenvironments of nature tissue and encapsulate cells 
homogeneously, which makes them attractive for cartilage tissue engineering. Both the mechanical and 
biochemical properties of hydrogels can affect the phenotype of chondrocytes. However, the influence of 
each property on chondrocyte phenotype is unclear due to the difficulty to separate the roles of these 
properties. In this part, we aimed to study the influence of hydrogel stiffness on chondrocyte phenotype 
while excluding the role of biochemical factors such as adhesion site density in the hydrogels. By altering the 
degree of methacryloyl functionalization, gelatin hydrogels with different stiffness of 3.8, 17.1 and 29.9 kPa 
Young’s modulus were prepared from the same concentration of gelatin methacryloyl (GelMA) macromers. 
Bovine articular chondrocytes were encapsulated in the hydrogels and cultured for 14 days. The influence of 
hydrogel stiffness on the cell behaviors including cell viability, cell morphology and maintenance of 
chondrogenic phenotype was evaluated. GelMA hydrogels with high stiffness (29.9 kPa) showed the best 
results on maintaining chondrogenic phenotype. These results will be useful for the design and preparation of 
scaffolds for cartilage tissue engineering. 
2.2 Introduction 
Cartilage defect is a common disease in our daily life, while the self-healing capacity of cartilage is very 
limited due to the lack of vasculature for nutrition supply. Therefore, articular cartilage repair using tissue 
engineering approach has drawn growing attention.[1] As we know, scaffolds, cells and growth factors are 
generally needed for tissue engineering. The interaction between cells and scaffolds plays an important role 
in controlling cell functions. Many factors can affect the cell-scaffold interaction, such as biological cues and 
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physical cues.[2,3] Biological cues are generally transmitted through the receptors on the cell membrane (e.g. 
integrin) and bioactive molecules in the extracellular matrices, which have been well studied.[4,5] The 
influence of physical cues, such as surface charges, topography and mechanical properties, on cell functions 
has also been extensively investigated.[6-9] As one of the physical cues, matrix stiffness has been reported to 
affect cell behaviors, such as cell spreading, migration, proliferation and differentiation.[10-13] Young’s 
modulus of native tissue is different depending on tissue types.[14] Therefore, the matrix stiffness needs to 
be optimized for different cell types and the cellular response to matrix stiffness should be well studied. The 
fates of some types of cells, such as fibroblasts,[15] neutrophils,[16] and mesenchymal stem cells 
(MSCs),[17] have been found to be affected by matrix stiffness. For chondrocytes, it has been reported that 
substrates with a low stiffness can help to maintain their chondrogenic phenotype due to the round 
morphology of chondrocyte.[18] However, the result is based on 2D cell culture on hydrogel surface that 
cannot well mimic the 3D mechanical microenvironment in native cartilage. Therefore, it is necessary to 
study the optimal stiffness of matrix for maintaining chondrogenic phenotype in 3D culture platform.  
A large variety of synthetic or natural materials have been used to fabricate hydrogels with controlled 
stiffness. For example, polyethylene glycol (PEG) hydrogels with Young’s modulus from 34 kPa to 1370 kPa 
have been synthesized through photo-polymerizing by using different concentrations of macromer.[19] 
Arginine-glycine-aspartic acid (RGD) peptide incorporating polyethylene glycol dimethacrylate (PEGDM) 
hydrogels with Young’s modulus from 2 kPa to 6 kPa have been used to study the chondrocyte extracellular 
matrix formation and phenotype maintenance.[20] Hydrogels of hyaluronic acid (HA),[21] agarose,[22] and 
alginate,[23] with gradient Young’s modulus have also be prepared by altering crosslinking density or 
macromer concentration. Gelatin as a proteinaceous material is derived from collagen by hydrolytic 
degradation.[24,25] Gelatin has similar chemical composition to that of collagen, which makes gelatin to be 
one of the most useful biomaterials for tissue engineering.[26-28] Gelatin hydrogels have been used to 
investigate the interaction between matrix and cells because of their similarity to the in vivo 
microenvironments.[29,30]  
To prepare gelatin hydrogels, photocrosslinking method has been proposed because of the advantages of 
injectability, mild cross-linking condition and low cytotoxicity.[31,32] Furthermore, the stiffness of 
photo-crosslinked gelatin hydrogels can be controlled by different degree of cross-linking. Introduction of 
methacryloyl group in gelatin molecules is a frequently used method to prepare photoreactive gelatin 
derivatives. Different strategies have been used to adjust the stiffness of gelatin methacryloyl (GelMA) 
hydrogels. It has been reported that the stiffness of GelMA hydrogels can be tethered from 5 kPa to 20 kPa 
by blending GelMA with other polymers, such as alginate and HA.[33] Variation of GelMA concentration 
can also result in different stiffness of GelMA hydrogels.[28,34] However, in these cases, it is difficult to 
separate the influence from stiffness and other factors, such as composition and concentration. Therefore, it 
is desirable to prepare hydrogels with different stiffness while keeping their composition and matrix 
concentration at the same level. Such hydrogels may separate the influence of stiffness from that of other 
factors, such as composition, matrix concentration and adhesion site density. 
In this study, the influence of matrix stiffness on the maintenance of chondrocyte phenotype was 
investigated by using a series of GelMA hydrogels that had different stiffness but the same gelatin 
concentration. The GelMA hydrogels were prepared by adjusting the degree of GelMA functionalization. 
Bovine articular chondrocytes were encapsulated in these hydrogels through photocrosslinking method and 
then cultured for 14 days. The behaviors and fates of chondrocytes in the hydrogels were studied by using 
cytoskeleton staining, ECM secretion assay, histological staining and gene expression. 
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2.3 Materials and methods 
2.3.1 Synthesis of GelMA macromers 
GelMA macromers were synthesized according to a previously described method.[35] 5 g gelatin (type 
A, 300 bloom, Sigma-Aldrich, MO, USA) was dissolved in 45 mL of phosphate buffered saline (PBS) at 60 
oC under stirring to obtain a 10 wt% aqueous gelatin solution. For the synthesis of GelMA macromer with 
high degree of functionalization (DoF), the pH of buffer solution was adjusted to 7.6 with 1N sodium 
hydroxide solution (Wako, Osaka, Japan) before gelatin dissolution. Different volume of methacrylic 
anhydride (MA, Sigma-Aldrich, MO, USA) (0.2 mL, 1 mL and 5 mL) was added into the gelatin solution at 
a rate of 0.5 mL/minutes under stirring at 50 oC to prepare GelMA with different introduction ratio of MA. 
After reaction in dark for 3 hours, the products were diluted with 5-fold warm PBS (50 oC) and then dialyzed 
against Milli-Q water for 7 days at 40 oC using a dialysis membrane (12-14 kD molecular weight cut-off, 
Spectrum Laboratories Inc. CA, USA) to remove salts and excess free MA. After that, the products were 
lyophilized for 2 days to obtain white porous foam and stored at -20 oC for further use. 
2.3.2 1H nuclear magnetic resonance (NMR) 
The degree of methacryloyl functionalization was quantified by using 1H NMR according to a 
previously described method.[36] 1H NMR spectra were collected by using an NMR spectrometer (AL300; 
JEOL, Tokyo, Japan) with a single axis gradient inverse probe at a frequency of 300 MHz. Before the 
measurement, 20 mg of GelMA macromers was completely dissolved in 1 mL deuterium oxide (containing 
0.05 wt% 3-(trimethylsilyl)propionic-2,2,3,3-d4 acid, sodium salt for calibration, Sigma-Aldrich, MO, USA). 
The gelatin without functionalization was also examined for calculating the degree of methacryloyl 
substitution using the following equation (1).  
DoF = 1- (lysine methylene proton of GelMA)/(lysine methylene proton of Gelatin) ×100%  (1) 
2.3.3 RGD density measurement 
The RGD density in GelMA macromers was quantified by reacting arginine groups with 9, 
10-phenanthrenequinone (Wako, Osaka, Japan) to produce a fluorescence compound. Briefly, 1 mg/mL 
gelatin or GelMA was mixed with 300 μL of an ethanol solution of 9, 10-phenanthrenequinone (150 μM) and 
50 μL of NaOH aqueous solution (2 N). The mixture was incubated at 60 °C under dark for 3 hours. Then 
200 μL of each sample was mixed with 200 μL of HCl (1.2 N) and the mixture was allowed to stand at room 
temperature under dark for 1 hour. The emission of the mixture was measured at an excitation wavelength of 
312 nm by an FP-6500 spectrofluorometer (JASCO, Tokyo, Japan).[37,38]  
2.3.4 Preparation of GelMA hydrogels 
GelMA macromers (10 wt%) and photo-initiator, 2-hydroxy-1-(4-(hydroxyethoxy) 
phenyl)-2-methyl-1-propanone (Irgacure 2959, Sigma-Aldrich, USA) (5 mg/mL), were dissolved in PBS at 
50 oC. The solution was added to the space between two quartz glass coverslips separated by a 1 mm-thick 
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spacer made from silicone gel sheet (KOKEN Co., Ltd., Tokyo, Japan). The construct was exposed to 365 
nm UV light (CL-1000, Funakoshi Co., Ltd., Japan) at a distance of 20 cm for 2 minutes. 
2.3.5 Mechanical testing  
Atomic force microscopy (AFM, MFP-3D-Bio) was applied to determine the stiffness of GelMA 
hydrogels. The hydrogel samples were incubated in PBS at 37 oC for 24 hours and then their stiffness was 
measured at room temperature. An optical microscope was used to control the position of the AFM tip. 
Silicon nitride cantilevers (Bruker, CA, USA) with a 600 nm diameter glass ball were used as the probe. The 
exact spring constant was measured before each experiment using a thermal tuning method. The force curves 
were collected and fitted to Hertz’s contact model to calculate Young’s modulus.[8] Three samples of each 
group were measured for calculation of means and standard deviations. 
2.3.6 Swelling ratio measurement 
To determine the mass swelling ratio, hydrogels were punched into disks with a 6 mm biopsy punch. 
The hydrogel disks were soaked in PBS at 37 oC for 24 hours. The samples were blotted with a KimWipe 
paper to remove the residual liquid and weighed to obtain the equilibrium wet weight. The dry weight was 
the sample weight after freeze-drying. The mass swelling ratio was calculated by dividing the equilibrium 
wet weight by the dry weight of the hydrogel disks.[34]  
2.3.7 Measurement of enzymatic degradation of hydrogels 
GelMA hydrogels with different stiffness were prepared and punched into disks with an 8 mm diameter 
biopsy punch following by swollen in PBS for 24 hours to reach swelling equilibrium. The swollen hydrogel 
disks were immersed in 2 ml of PBS containing 10 units mL-1 of collagenase (Worthington Biochemical, 
Lakewood, USA) and incubated at 37 oC in an orbital shaker at a shaking speed of 60 rpm. At the time points 
of 1, 2, 4, 9 and 20 hours, the hydrogel samples were taken out and weighed after being blotted. The 
degradation degree of the hydrogels was determined by normalizing the residual hydrogel wet weight to the 
initial wet weight. Three samples were used at every time point for the measurement to calculate means and 
standard deviations. 
2.3.8 Culture of chondrocytes in hydrogels  
Chondrocytes were isolated from articular cartilage from the knees of a 9 week-old calf according to 
previously reported protocol.[39,40] The isolated primary chondrocytes were cultured in 75 cm2 tissue 
culture flasks in Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum, 
4500 mg L-1 glucose, 4 mM glutamine, 100 U mL-1 penicillin, 100 µg mL-1 streptomycin, 0.1 mM 
nonessential amino acids, 0.4 mM proline, 1 mM sodium pyruvate and 50 µg mL-1 ascorbic acid at 37 oC and 
5% CO2. The cells were subcultured after confluence and the cell culture medium was refreshed every 3 days. 
The chondrocytes at passage 2 were used in the following experiments. The cells were detached with a 
trypsin/EDTA solution, collected by centrifugation, counted with a hemocytometer and resuspended in the 
PBS solutions containing GelMA macromers (111 mg/mL) and photo-initiator Irgacure 2959 (5 mg/mL) to 
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obtain cell suspension at a density of 2 × 107 cell/mL. The suspension solution was used to prepare cell-laden 
hydrogels in the same manner as above described. The quartz glass coverslips were sterilized before usage 
and all the experimental procedures were conducted sterilely in a clean bench. The cell-laden hydrogels were 
then punched into disks (6 mm diameter × 1 mm thickness) with a sterile 6 mm biopsy punch. The cells in 
the hydrogel disks were cultured in DMEM medium at 37 oC and 5% CO2 under shaking for 14 days and the 
medium was changed every two days.  
2.3.9 Cell viability assay 
Live/dead staining was performed to evaluate cell viability of chondrocytes in the hydrogels by using 
Cellstain Double Staining Kit (Dojindo Laboratories, Tokyo, Japan). After 1 and 7 days of culture, the 
cell-laden hydrogel disks were washed with PBS and incubated with serum-free medium containing 
calcein-AM (2 µM) and propidium iodide (4 µM) for 15 minutes. After that, the live cells and dead cells in 
the interior areas of hydrogels were observed under a fluorescence microscope. 
2.3.10 Cytoskeleton actin filament staining 
The cytoskeleton of chondrocytes in the hydrogels after 7 and 14 days of culture was observed by actin 
filament (F-actin) staining. The cell-laden hydrogel disks were washed with PBS for 3 times, fixed with 4 % 
paraformaldehyde at 4 oC for 24 hours and further washed 2 times with PBS. Then the cell-laden hydrogel 
disks were immersed in 5 mL of 0.2% Triton X-100 for 50 minutes to permeabilize the cells. After being 
washed with PBS for 3 times and blocked with 1% bovine serum albumin (BSA) solution at room 
temperature for 30 minutes, the samples were immersed in 1 mL PBS containing 40-fold diluted Alexa 
FluorVR 488 phalloidin (Invitrogen, Carlsbad, CA) for 60 minutes to stain actin filaments. Cell nuclei were 
stained with 1000-fold diluted 4’, 6-diamidino-2-phenylindole dihydrochloride (DAPI, Dojindo Laboratories, 
Tokyo, Japan) solution in PBS at room temperature for 10 minutes. After staining, cell-laden hydrogel disks 
were rinsed with PBS again and their fluorescence images were captured using a confocal microscope (Zeiss 
LSM 510 Meta, Oberkochen, Germany).  
2.3.11 Histological stainings 
After 14 days of culture, the cell-laden hydrogel constructs were washed with PBS and fixed with 10% 
neutral buffer formalin at room temperature for 2 days. After that, the samples were dehydrated in a series of 
ethanol solution with increasing ethanol concentration from 70% to 99.5%, embedded in paraffin and 
sectioned to obtain cross-sections having 5 µm thickness. The cross-sections were deparaffinized and stained 
with hematoxylin and eosin dyes (HE staining) for cell morphology and safranin-O dye for 
glycosaminoglycan. The stained samples were observed under an optical microscope. 
2.3.12 Quantification of DNA and sulfated glycosaminoglycan (sGAG)  
DNA amount in each hydrogel was quantified to evaluate the proliferation of chondrocytes. The 
cell-laden hydrogels with different stiffness were harvested and freeze-dried after being cultured for 14 days. 
The freeze-dried cell-laden constructs were digested by 500 µL papain solution (Sigma-Aldrich, MO, USA) 
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prepared by dissolving papain at a concentration of 400 mg mL-1 in 0.1 M phosphate buffer (pH 6.0) 
containing 5 mM cysteine hydrochloride and 5 mM ethylenediaminetetraacetic acid (EDTA). 10 µL of 
papain digestion solution was used to measure the DNA content by using Hoechst 33258 dye (Sigma-Aldrich, 
MO, USA) to produce fluorescence. The fluorescence intensity was read with an FP-6500 
spectrofluorometer (JASCO, Tokyo, Japan) at an excitation/emission wavelength of 360 nm and 460 nm. The 
sGAG content in each digestion solution was measured by using BlyscanTM Glycosaminoglycan Assay Kit 
(Biocolor, County Antrim, UK) according to the instruction offered by the product. Three samples in each 
group were used for the measurement to calculate means and standard deviations. 
2.3.13 Real-time PCR analysis 
Expression of genes encoding collagen type II and aggrecan in the chondrocytes cultured in the different 
stiffness hydrogels was analyzed by a real-time polymerase chain reaction (real-time PCR).[41] After being 
cultured for 14 days, the cell-laden hydrogel samples were washed with PBS for 3 times, frozen in liquid 
nitrogen and crushed into powder by an electric crusher. The powder samples were dissolved in Sepasol 
solution (1 mL per sample) to isolate the contained RNA. The RNA was converted to cDNA by MuLV 
reverse transcriptase (Applied Biosystems, Massachusetts, USA). Real-time PCR was used to amplify 
glyceraldehyde-3-phosphate dehydrogenase (Gapdh), type II collagen (Col2a1) and aggrecan (Acan). The 
reactions were run for 40 cycles using a 7500 real-time PCR System (Applied Belgium, USA). The 
expression level of Gapdh, a housekeeping gene, was used as an endogenous control. The expression level of 
the target gene was then calculated using the 2-ΔΔCt formula with reference to the chondrocytes from 2D 
expansion culture. The primer and probe sequences were chosen according to a previous study. Three 
samples in each group were used for the measurement to calculate means and standard deviations. 
2.3.14 Statistical analysis 
All data were reported as the mean ± standard deviation (SD). Statistical analysis was performed using a 
one-way analysis of variance and Tukey's post hoc test for multiple comparisons. All statistical analyses were 
executed using KyPlot 2.0 beta 15. 
2.4 Results and discussion 
2.4.1 Synthesis and characterization of GelMA macromers 
The GelMA macromers with three different degrees of functionalization were synthesized by adjusting 
the volume of methacrylic anhydride (0.2 mL, 1.0 mL and 5.0 mL per 5 g gelatin) during the reaction. The 
conjugation of methacryloyl groups to gelatin molecules was confirmed by the 1H NMR spectra (Figure 2.1). 
The increase of signal at δ = 5.4 and 5.7 ppm (the proton of methacrylate vinyl group of MA) and a decrease 
of the signal at δ = 2.9 ppm (the protons of methylene of lysine signal) confirmed the increase of 
modification degree with the feed MA amount. Because the proton signal of the aromatic amino acid 
moieties in gelatin remained constant, their intensity was used to normalize the intensity of other protons in 
different samples. Therefore, the DoF was calculated by comparing the proton signal at δ = 2.9 ppm of 
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unmodified gelatin and GelMA. The DoF of the three types of GelMA macromers increased from 25.8 ± 
0.7 % to 91.7 ± 1.4 % by adjusting the feed ratio of MA to gelatin (Table 2.1). 
 
 
Figure 2.1 1H NMR spectra of unmodified gelatin (Gel), GelMA macromers with different DoF (Low 
GelMA, Medium GelMA and High GelMA). 
 
Table 2.1 The DoF of Low GelMA, Medium GelMA and High GelMA 
 
Sample Feed ratio of Gel (g)/MA (mL) DoF (%) 
Low GelMA 5 / 0.2 25.8 ± 0.7 
Medium GelMA 5 / 1.0 52.5 ± 1.2 
High GelMA 5 / 5.0 91.7 ± 1.4 
2.4.2 RGD density in gelatin and GelMA macromers 
The arginine residues in gelatin also have amino groups that may react with MA. Therefore the content 
of arginine residues in the GelMA macromers was measured to confirm if the RGD density was changed 
after the modifications. The amino groups in arginine residues can react with 9, 10-phenanthrenequinone to 
produce a fluorescence compound. Unmodified gelatin and the three types of GelMA macromers with low, 
medium and high DoF had almost the same level of fluorescence absorbance (Figure 2.2). Blank control 
without RGD prepared by deionized water did not show obvious fluorescence absorbance at the wavelength 
range. The results indicated that the arginine content in Gel and GelMA macromers was almost the same, 
which suggests that the arginine should be not involved in the reaction even at a high DoF. Therefore the 
RGD density in all the GelMA hydrogels prepared from the three types of GelMA macromers should be kept 
at the same levels, which was important to exclude the influence of different density of active RGD motifs. 
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Figure 2.2 Photoluminescence spectra of 9, 10-phenanthrenequinone after reaction with gelatin and GelMA 
macromers.  
2.4.3 Young’s modulus and swelling ratio of GelMA hydrogels 
Three types of hydrogels were prepared from GelMA macromers with the same concentration of gelatin 
(10 wt%) but different DoF. The stiffness of GelMA hydrogels was measured by AFM. The GelMA 
hydrogels prepared from GelMA with low, medium and high DoF had Young’s modulus of 3.8 ± 0.3, 17.1 ± 
2.4 and 29.9 ± 3.4 kPa, respectively (Figure 2.3a). As expected, high DoF resulted in GelMA hydrogels with 
significantly increased Young’s modulus. The results showed that the GelMA hydrogels with a broad range 
of stiffness could be generated by adjusting the DoF of macromers.  
Swelling ratio of hydrogels is an important factor that should be considered for tissue engineering 
application. The swelling ratio of GelMA hydrogels with low, medium and high stiffness was calculated to 
be 17.89 ± 1.24, 8.86 ± 0.20 and 7.20 ± 0.12, respectively (Figure 2.3b). Clearly, the swelling ratio of 
hydrogels decreased with the increase of stiffness. This may be because the high DoF of methacryloyl in 
high stiffness GelMA hydrogel could increase the density of cross-linking network. The high cross-linking 
density could restrain the swelling of the hydrogels and result in a low swelling ratio.  
 
Figure 2.3 Young’s modulus (a) and equilibrium swelling ratio (b) of GelMA hydrogels with high, medium 
and low stiffness. Means ± SD, N=3. ***, P < 0.001; **, P < 0.01.  
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2.4.4 Enzymatic degradation of GelMA hydrogels 
It is necessary to investigate the biodegradability of hydrogels before their biomedical applications. The 
enzymatic degradability of GelMA hydrogels with different stiffness was examined in the presence of 
collagenase. Collagenase is a member of the matrix metalloproteinase (MMP) family that can degrade and 
remodel the extracellular matrix for cell spreading and migration.[42] Herein, collagenase was used because 
it can accelerate the degradation of proteolysis-sensitive gelatin hydrogels. The weight loss rate of low, 
medium and high stiffness GelMA hydrogels after treatments with collagenase is shown in Figure 2.4 
GelMA hydrogels with higher stiffness were degraded more slowly when compared to those with lower 
stiffness. These results suggested that the enzymatic degradability of GelMA hydrogels could be controlled 
by the degree of cross-linking and hydrogel stiffness. Higher cross-linking degree resulted in higher stiffness 
and slower degradation. 
 
Figure 2.4 Enzymatic degradation of GelMA hydrogels in the presence of 10 unit mL-1 of collagenase at 37 
oC. Means ± SD, N=3. 
2.4.5 Cell viability in GelMA hydrogels 
Cell viability was investigated by live/dead staining after chondrocytes were encapsulated in the GelMA 
hydrogels and cultured for 1 and 7 days. In all the groups, most of the chondrocytes were alive (green color) 
and only a few dead cells were observed (red color) after 1 and 7 days of culture (Figure 2.5). The results 
indicated that the cells in the hydrogels had high cell viability even after the photocrosslinking process, 
suggesting that it may be a good strategy to use the GelMA hydrogels for cell encapsulation. Furthermore, 
the live cell density seemed to be the same for all the GelMA hydrogels, suggesting that the stiffness of 
GelMA did not have an obvious influence on cell viability. 
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Figure 2.5 Live/dead staining of chondrocytes cultured in the GelMA hydrogels for 1 day and 7 days. Scale 
bar = 100 µm. (Green: live cells; Red: dead cells) 
2.4.6 Cytoskeleton organization in GelMA hydrogels 
Immunofluorescence staining of F-actin was performed to visualize the cellular morphology and 
cytoskeleton organization in the hydrogels (Figure 2.6). Chondrocytes in the high stiffness GelMA hydrogels 
had almost round shape and no obvious F-actin stretch, which indicated that the cell did not spread well after 
being cultured in the high stiffness hydrogels for 7 and 14 days. Furthermore, some cell clusters were 
observed in the high stiffness GelMA hydrogels. In contrast, the cell elongated in the low stiffness GelMA 
hydrogels with abundant F-actin filaments after culture for 7 and 14 days. Chondrocytes cultured in the 
medium stiffness GelMA hydrogels showed round morphology after 7 days of culture and spreading 
morphology after 14 days of culture. The results indicated that cell morphology could be controlled by the 
stiffness of hydrogels. 
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Figure 2.6 Confocal laser microscopy images of chondrocytes that were stained with F-actin (green) and cell 
nuclei (blue) after being cultured in GelMA hydrogels for 7 days (a, b) and 14 days (c, d). (a, c) scale bar = 
20 µm; (b, d) scale bar = 5 µm. 
 
Cytoskeletal configuration and regulation have been reported to play an important role in the process of 
chondrogenesis.[43] It was recognized that round cell morphology and decreased actin cytoskeletal 
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organization are beneficial for the chondrogenesis of mesenchymal stem cells (MSCs).[43,44] Spherical 
aggregation was also beneficial for chondrogenesis due to the increased intercellular contacts.[45,46] The 
high stiffness GelMA hydrogels had a higher Young’s modulus and a higher degree of cross-linking, which 
inhibited cell spreading and resulted in weak F-actin filament network formation. The microenvironment of 
high stiffness hydrogel also promoted spherical aggregation. Similar cell morphology was observed in 
medium stiffness GelMA hydrogels after 7 days of culture. However, most cells in the medium stiffness 
GelMA hydrogels spread after 14 days of culture, which might be due to the continuous proteolytic 
degradation of hydrogels. This suggested the hydrogels with high stiffness could support the maintenance of 
the round morphology of chondrocytes, in agreement with the previous study.[47] 
2.4.7 Histological stainings 
Cell morphology and cartilaginous matrices production of the chondrocytes after 14 days of culture in 
the GelMA hydrogels were further investigated by histological staining (Figure 2.7). HE staining indicated a 
homogeneous cell distribution for all the GelMA hydrogels. The chondrocytes showed round morphology in 
the high stiffness GelMA hydrogels, while partially spreading morphology in medium stiffness GelMA 
hydrogels. In contrast, cells in the low stiffness GelMA hydrogels showed an elongated morphology. The 
elongation of cells in low stiffness hydrogels might be a signal of losing chondrogenic phenotype.[43,44] 
Safranin-O staining indicated that more proteoglycans were detected in the high stiffness GelMA hydrogels 
than the other two groups. The cells cultured in medium stiffness GelMA hydrogels showed partially positive 
staining of proteoglycans, while the chondrocytes cultured in the low stiffness GelMA hydrogels lost their 
proteoglycans secretion capacity obviously. 
One reason for these results may be that high stiffness offered a better stimulus to chondrocyte through 
the pathways to maintain their chondrogenic phenotype in 3D culture.[44,48,49] Another reason may be that 
the GelMA hydrogels with high stiffness could promote the chondrocytes cluster formation. The 
chondrocytes aggregation has been reported to facilitate the outcome of cartilage repair,[50,51] because 
cell-cell interaction plays a critical role in chondrogenesis.[52-54] The staining results indicated that GelMA 
hydrogels with high stiffness could support the chondrogenic phenotype. 
 
Figure 2.7 HE and safranin-O stainings of chondrocytes cultured in the GelMA hydrogels for 14 days.  
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2.4.8 Quantification of DNA, cartilaginous matrices and gene expression 
To investigate whether the stiffness affects cell proliferation, DNA amount measurement was performed 
after the cells were cultured in the GelMA hydrogels for 14 days (Figure 2.8a). The cells cultured in different 
GelMA hydrogels showed almost the same DNA amount, indicating the stiffness of hydrogels had no 
obvious influence on cell proliferation. 
 
Figure 2.8 DNA amount (a), sGAG/DNA ratio (b) and expression of genes encoding collagen type II (c) and 
aggrecan (d) of chondrocytes cultured in the GelMA hydrogels for 14 days. Means ± SD, N=3. **, P < 0.01; 
*, P < 0.05. 
 
The secretion of ECM proteins is very important for cartilage regeneration because chondrocytes in 
cartilage are surrounded by abundant ECMs, such as sGAG. The sGAG/DNA ratio was calculated from the 
amount of sGAG and DNA to show the production capacity of cartilaginous ECM by each cell (Figure 2.8b). 
The sGAG/DNA ratio of chondrocytes in high stiffness GelMA hydrogels was significantly higher than the 
other groups after 14 days of culture. No significant difference could be seen in the medium and low stiffness 
GelMA hydrogels. 
The expression of genes encoding the two typical cartilaginous matrices (collagen type II and aggrecan) 
was analyzed by real-time PCR (Figure 2.8c, 2.8d). Chondrocytes cultured in high stiffness GelMA 
hydrogels showed the highest expression level of collagen type II and aggrecan genes after 14 days of culture. 
The quantification data of cartilaginous matrices and their gene expression were in good agreement with the 
staining results, indicating that chondrocytes cultured in the high stiffness GelMA hydrogels had the best 
maintenance capacity of chondrogenic phenotype.  
The rapid degradation and stress relaxation characters of low stiffness GelMA hydrogels may promote 
the dedifferentiation of chondrocytes as they down-regulated the gene expression of collagen type II and 
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aggrecan. It has been reported that high spreading can be observed in physiological extracellular matrices 
with high degradation rate and quick stress relaxation.[55,56] All of our results suggested the GelMA 
hydrogels with high stiffness had the best function for the maintenance of chondrocyte phenotype. 
The results of this study are different from some previous studies.[19,20,22] Some previous studies have 
reported that lower stiffness hydrogels had a better maintenance function of chondrogenic phenotype. The 
difference of stiffness range and material properties between this study and the previous studies might be the 
reasons for the different results. The high stiffness in this study was at the same range as the low stiffness of 
the previous studies. The Young’s modulus of hydrogels in this study was controlled to mimic the 
mechanical property of cartilage ECM.[57-59] However, the stiffness range was far from the rigidity of 
native cartilage (400-800 kPa).[59,60] This might be one reason. The materials property including adhesion 
sites and degradable sites might be another reason. In PEG, agarose and HA hydrogels, cells keep round 
shape in lower stiffness hydrogels until sufficient extracellular matrices are produced.[61,62] But in 
gelatin-based hydrogels, cells can easily spread.[55] The presence of RGD in the hydrogels can promote cell 
spreading. It is important to investigate the influence of matrix stiffness on chondrogenic phenotype by using 
natural ECM protein materials (collagen and gelatin etc.) because they have RGD and MMP degradable 
sequences to better mimic the microenvironment as compared with other natural polymer or synthetic 
materials, such as HA and PEG. 
2.5 Conclusions 
GelMA hydrogels with different stiffness and same RGD density were fabricated by adjusting the 
degree of methacryloyl substitution of same concentration of gelatin. The Young’s modulus increased with 
the degree of functionalization. Cell cultured in the hydrogels showed high viability. Bovine chondrocytes 
cultured in the high stiffness GelMA hydrogels showed rounder morphology, secreted more cartilaginous 
matrices and exhibited higher expression of collagen II and aggrecan genes compared to the cells cultured in 
medium and low stiffness GelMA hydrogels. The high-stiffness GelMA hydrogels had the highest capacity 
on maintaining the phenotype of chondrocytes.  
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Chapter 3 
Fabrication of highly crosslinked gelatin hydrogel and its influence 
on chondrocyte proliferation and phenotype 
 
 
 
3.1 Summary 
Gelatin methacrylate (GelMA) hydrogels have been widely studied for biomedical applications, such as 
tissue engineering and drug delivery, because of their good biocompatibility and injectability. However, the 
quick degradation and low mechanical property of GelMA hydrogels need to be improved for further 
applications, especially for long-term implantation. In this part, a sequential double modification of gelatin 
was used to achieve high density of photocrosslinkable double bonds in gelatin derivatives. The amino 
groups in gelatin were first reacted with methacrylic anhydride. After this, the hydroxyl and carboxyl groups 
in gelatin were reacted with glycidyl methacrylate to obtain the double modified gelatin macromer. The 
double modified gelatin macromer was used to prepare gelatin hydrogels with high crosslinking density. The 
hydrogels exhibited high storage modulus and low degradation. Culture of bovine articular chondrocytes in 
the gelatin hydrogels showed that chondrocytes had round morphology and maintained a cartilaginous 
phenotype while cell proliferation was hampered. This method for increasing crosslinking density should be 
useful for preparation of stable hydrogels for cartilage tissue engineering. 
3.2 Introduction 
Cartilage tissue engineering has drawn a lot of attention due to the limited self-repairing capacity of 
avascular cartilage. One crucial step of cartilage tissue engineering is in vitro expansion of chondrocytes, 
during which chondrocytes lose part of their chondrogenic phenotype due to the differences between the 
two-dimensional (2D) expansion culture microenvironment and the in vivo three-dimensional (3D) 
microenvironment. The loss of expression of cartilaginous matrices, such as collagen type II and aggrecan is 
a process known as de-differentiation. De-differentiated chondrocytes should be re-differentiated in order to 
express cartilaginous matrices for functional cartilage tissue engineering.[1] Hydrogels have been frequently 
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used for the 3D culture of chondrocytes for re-differentiation and maintenance of chondrogenic phenotype 
and for chondrogenic differentiation of stem cells.[2-4] Hydrogels are hydrated polymers with 3D network 
structures that are similar to the microenvironments surrounding chondrocytes in vivo.[5] Many reports have 
shown the re-differentiation of de-differentiated chondrocytes in hydrogels.[6] Among the hydrogels, gelatin 
hydrogels have many advantages, such as good cell adhesion (RGD peptide), good biocompatibility and easy 
modification.[7-11] 
Gelatin is usually modified with methacrylate groups for gelatin hydrogel preparation. The main 
limitations of GelMA hydrogel for tissue engineering, especially for the tissues requiring extensive 
load-bearing properties, are its poor mechanical properties and short degradation time.[12,13] The 
mechanical properties and degradation of hydrogels are related to hydrogel network crosslinking density.[14] 
The compressive modulus increases as the crosslinking density increases.[15] Altering precursor macromer 
concentration has been reported to modulate crosslinking density of hydrogels.[16] However, altering 
macromer concentration cannot decouple the influence of hydrogel matrix concentration. It is particularly 
important for gelatin hydrogel because gelatin holds RGD sequences and different gelatin concentrations 
may result in different densities of RGD. Other methods to increase crosslinking density include prolonging 
of crosslinking time.[17] However, long UV irradiation time may decrease cell viability. Incorporation of 
more photo-reactive double bonds to increase the ratio of photocrosslinkable bonds to photo-initiator during 
hydrogel preparation has been proposed as an attractive method to increase crosslinking density because a 
high ratio of photocrosslinkable bonds to photo-initiator can protect cells from free radical attack and 
therefore lead to high cell viability.[18]  
For the methacrylation of gelatin molecules, amino groups are usually used for reaction with 
methacrylate groups. However, the number of amino groups in each gelatin molecule is limited. There are 
many hydroxyl and carboxyl groups in gelatin molecules. Therefore, usage of these functional groups for 
further methacrylation of gelatin is desirable to increase the crosslinking density of gelatin hydrogels. 
In this study, a sequential double modification of amino, hydroxyl and carboxyl groups of gelatin 
molecules was used to introduce more photocrosslinkable methacrylate groups in gelatin for the preparation 
of gelatin hydrogels with a high crosslinking density. The elastic property and enzymatic degradation rate of 
the hydrogel were evaluated. The gelatin hydrogels were used for 3D culturing of chondrocytes, and their 
effects on cell proliferation and expression of cartilaginous matrices were investigated.   
3.3 Materials and methods 
3.3.1 Synthesis of GelMA and GelMAGMA 
GelMA macromer was synthesized according to a previously described method.[7] Briefly, 5 g gelatin 
(type A, 300 bloom, Sigma-Aldrich, St. Louis, MO, USA) was dissolved in phosphate buffered saline (PBS) 
at 50 oC under stirring to obtain a 10% (w/v) gelatin solution. 5 mL methacrylic anhydride (MA; 
Sigma-Aldrich, St. Louis, MO, USA) was added into the gelatin solution at a rate of 0.5 mL/minute while 
stirring at 50 oC to prepare GelMA. After reaction in the dark for 3 hours, the product was diluted with 
five-fold warm PBS (50 oC) and then dialyzed against Milli-Q water for seven days at 40 oC using a dialysis 
membrane (12-14 kD molecular weight cut-off, Spectrum Laboratories Inc. USA) to remove salts and excess 
free MA. The GelMA foam was obtained after freeze-drying for two days. 
Glycidyl methacrylate-modified GelMA (GelMAGMA) macromer was synthesized by modifying the 
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GelMA macromer with glycidyl methacrylate.[19] After dissolving 2.5 g of GelMA macromer in Milli-Q 
water (2%, w/v), the pH of the solution was adjusted to 3.5 with 1 M HCl (Wako, Osaka, Japan). After this, 5 
mL of glycidyl methacrylate (GMA; Sigma-Aldrich, St. Louis, MO, USA) was added into the solution at a 
rate of 0.5 mL/minute.[20] The reaction was conducted at 50 oC for 24 hours and the product was purified by 
dialysis against Milli-Q water with the above-mentioned dialysis membrane at 40 oC for seven days. The 
purified product was freeze-dried and stored at -20 oC for further use. 
3.3.2 1H nuclear magnetic resonance (NMR) 
The degree of functionalization was studied by using 1H NMR according to a previously reported 
method.[21] 1H NMR spectra were collected by using an NMR spectrometer (AL300; JEOL, Tokyo, Japan) 
with a single axis gradient inverse probe at a frequency of 300 MHz. Before the measurement, 30 mg of 
GelMA and GelMAGMA macromers were respectively dissolved into 1 mL deuterium oxide containing 
0.05% (w/v) 3-(trimethylsilyl)propionic-2,2,3,3-d4 acid sodium salt (Sigma-Aldrich, St. Louis, MO, USA) 
for calibration at 40 oC. 
3.3.3 Preparation of GelMA and GelMAGMA hydrogels 
GelMA and GelMAGMA solutions were prepared by dissolving the respective macromers (10%, w/v) 
and photoinitiator, 2-hydroxy-1-(4-(hydroxyethoxy) phenyl)-2-methyl-1-propanone (I 2959, Sigma-Aldrich, 
St. Louis, MO, USA), (0.5%, w/v) in PBS solution at 50 oC. The above solutions were sterilized by filtration 
through a 0.22 µm filter (Millex-GV, Carrigtohill, Cork, Ireland). After sterilization, the solution was 
pipetted between two sterile quartz glass coverslips separated by a sterile silicone membrane frame with a 
1.5 mm thickness (KOKEN Co., Ltd., Tokyo, Japan) and exposed to UV light (CL-1000, Funakoshi Co., 
Ltd., Japan) for 5 minutes. After cross-linking, the hydrogels were punched into disks with a 10 mm biopsy 
punch (Acu-Punch, Acuderm Inc, Fla, USA) for rheological testing and a 6 mm biopsy punch (Kai Medical, 
Gifu, Japan) for the other experiments. 
3.3.4 Rheological measurements 
The storage modulus of GelMA and GelMAGMA hydrogel disks (10 mm of diameter) were measured 
by an MCR301 Rheometer (Anton Paar, Germany) equipped with 10 mm parallel plates. The temperature 
was set at 37 oC, and the samples were balanced for 3 minutes before the start of testing. The storage moduli 
of GelMA and GelMAGMA hydrogels were measured by an oscillatory shear deformation at a constant 
frequency (1 Hz) and a constant shear strain (5%).[21] Three samples were tested to calculate means and 
standard deviations. 
3.3.5 Swelling ratio and enzymatic degradation of the hydrogels 
GelMA and GelMAGMA hydrogel disks (6 mm of diameter) were swollen in PBS for 24 hours to reach 
swelling equilibrium. The samples were blotted with a KimWipe paper to remove the residual liquid and 
weighed to obtain the equilibrium wet weight. The dry weight was measured after freeze-drying. The 
swelling ratio was calculated according to a previous report.[22] Three samples were used for the 
Chapter 3 
54 
 
measurement to calculate means and standard deviations. 
The swollen hydrogel disks were immersed in 5 ml of PBS containing 10 units mL-1 of collagenase I 
(Worthington Biochemical, Lakewood, NJ, USA) and incubated at 37 oC in an orbital shaker at a shaking 
speed of 100 rpm. At the designated time points, the hydrogel disks were taken out and weighed after the 
removal of the excess solution by blotting. The degradation degree of the hydrogels was calculated by 
normalizing the residual hydrogel wet weight to the initial wet weight. Five samples were used at every time 
point for the measurement to calculate means and standard deviations. 
3.3.6 Chondrocytes isolation and culture in vitro 
Bovine articular chondrocytes (BACs) were isolated from articular cartilage from the knees of a calf 
according to previously reported protocol.[23] Briefly, the articular cartilage tissue was minced into small 
pieces using a sterile surgery scalpel. The minced tissue pieces were digested with a 0.2% w/v collagenase 
type II (Worthington Biochemical, Lakewood, NJ, USA) aqueous solution overnight at 37 oC with shaking. 
The digestion solution was filtered through a sterile nylon mesh with a 70 µm mesh size to remove any 
undigested fragments. The isolated primary chondrocytes were collected by centrifugation and cultured in 75 
cm2 tissue culture flasks in Dulbecco’s Modified Eagle Medium (D6546; Sigma-Aldrich, St. Louis, MO, 
USA) supplemented with 10% fetal bovine serum, 4500 mg L-1 glucose, 4 mM glutamine, 100 U mL-1 
penicillin, 100 µg mL-1 streptomycin, 0.1 mM nonessential amino acids, 0.4 mM proline, 1 mM sodium 
pyruvate and 50 µg mL-1 ascorbic acid at 37 oC and 5% CO2. The culture medium was refreshed every three 
days. The cells were subcultured after reaching confluence. The chondrocytes at passage 2 were used in the 
following experiments. The cells were detached with a trypsin/EDTA solution, collected by centrifugation, 
counted with a hemocytometer and re-suspended in the mixture solution of GelMA or GelMAGMA 
macromer (10%, w/v) and photo-initiator (0.5 %, w/v) sterilized by 0.22 µm filter. The cell suspension 
solution was added between two quartz glass coverslips separated by a 1.5 mm-thick silicone membrane 
frame and exposed to UV light to prepare cell-laden GelMA or GelMAGMA hydrogel as described in section 
2.3. The quartz glass and silicone frame were sterilized by 70% ethanol and washed with PBS. The cell-laden 
hydrogels were punched into disks with a 6 mm biopsy punch. Before culturing, all the samples were washed 
twice to remove the photo-initiator by immersing in culture medium for 30 minutes. The cell-laden hydrogel 
disks were transferred to cell culture T-flasks for dynamic cell culture under shaking (60 rpm). The culture 
medium was changed every two days. All the procedures were conducted under sterile conditions on a clean 
bench. The UV crosslinking machine was sterilized by 70% ethanol and moved into the clean bench before 
UV crosslinking. As a two-dimensional culture control, the passage 2 chondrocytes were seeded in 24-well 
tissue culture plates (TCP) and cultured with the same medium as that used for three-dimensional culture in 
the hydrogels. 
3.3.7 Cell viability assay 
Live/dead staining was performed to evaluate cell viability of chondrocytes in the hydrogels by using 
Cellstain Double Staining Kit (Dojindo Laboratories, Tokyo, Japan). After UV crosslinking and 14 days of in 
vitro culture, the cell-laden hydrogel disks were washed with PBS for three times and incubated with 
serum-free medium containing calcein-AM (2 µM) and propidium iodide (4 µM) at 37 oC for 15 minutes. 
The stained cells were observed using a confocal microscope (Zeiss LSM 510 Meta). 
GelMAGMA hydrogel and its influence on chondrocytes 
55 
 
3.3.8 In vivo implantation 
All the animal experiment procedures were approved by the Animal Experiments Committee of the 
National Institute for Materials Science and the experiment was conducted according to the committee 
guidelines. After the cell-laden hydrogel disks were cultured in the culture medium under shaking for one day, 
they were subcutaneously implanted in the dorsa of athymic nude mice. After six weeks of implantation, the 
mice were euthanized and the implants were harvested for further study.   
3.3.9 Quantification of DNA and sulfated glycosaminoglycan (sGAG)  
DNA amount and sGAG content in the hydrogel disks were quantified after six weeks of implantation. 
The harvested cell-laden hydrogel disk implants were washed with PBS three times and freeze-dried. Each of 
the freeze-dried implants was digested by 500 µL papain solution (Sigma-Aldrich, St. Louis, MO, USA), 
which was prepared by dissolving papain at a concentration of 400 mg/mL in 0.1 M PBS (pH 6.0) containing 
5 mM cysteine hydrochloride and 5 mM ethylenediaminetetraacetic acid (EDTA). 5 µL of the papain 
digestion solution was used to measure the DNA amount with Hoechst 33258 dye (Sigma-Aldrich, St. Louis, 
MO, USA). The fluorescence intensity was read with an FP-6500 spectrofluorometer (JASCO, Tokyo, Japan) 
at an excitation/emission wavelength of 360 nm and 460 nm. The sGAG content in each digestion solution 
was measured by using a BlyscanTM Glycosaminoglycan Assay Kit (Biocolor Ltd., County Antrim, UK). 
Four samples in each group were used for the measurement to calculate means and standard deviations. 
3.3.10 Histological and immunohistochemical staining 
The harvested cell-laden hydrogel disk implants were washed three times with PBS and fixed with 10% 
neutral buffer formalin (Wako, Osaka, Japan) at room temperature for two days. After that, the implants were 
dehydrated in a series of ethanol solutions with increasing ethanol concentration from 70% to 99.5%, 
embedded in paraffin and sectioned with a microtome (Leica RM2245; Germany) to obtain cross-sections 
having a 7 µm thickness. The cross-sections were then de-paraffinized and stained with hematoxylin and 
eosin (HE) for cell morphology; and safranin O/fast green and alcian blue for glycosaminoglycan. Briefly, 
the de-paraffinized sections were immersed in hematoxylin solution for 10 minutes, and then washed with 
tap water for 10 min before immersing in eosin solution for 3 minutes. For safranin O/fast green staining, the 
de-paraffinized sections were stained with 0.02% aqueous solution of fast green for 1 minute, followed by 
washing with tap water, immersion in 1% acetic acid aqueous solution for 15 seconds and immersion in 
0.1% safranin O aqueous solution for 10 minutes. The alcian blue staining was conducted by immersing the 
de-paraffinized sections in alcian blue aqueous solution for 30 minutes. The immunohistochemical staining 
of collagen type II and collagen type I was performed according to a previous report.[24] Briefly, the 
de-paraffinized sections were incubated with proteinase K (Dako Corp., Carpinteria, CA, USA) for 10 
minutes for antigen retrieval, and then incubated with peroxidase blocking solution (Dako) for 5 minutes and 
10% goat serum solution (Dako) for 30 minutes. Next, the sections were incubated with the first antibodies 
for 2 hours at room temperature, followed by incubation with the peroxidase-labeled polymer-conjugated 
second antibodies (DakoCytomation Envision+, Dako, Carpinteria, CA, USA) for another 30 minutes at 
room temperature. The first antibodies were rabbit polyclonal anti-collagen type II at a 1:100 working 
dilution (AB746; Millipore, Schwalbach, Germany) and rabbit monoclonal anti-collagen type I at a 1:100 
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working dilution (AB138492; Abcam, Cambridge, MA, USA). The second antibody was HRP-labeled 
polymer conjugated secondary antibody (anti-rabbit; Dako, Carpinteria, CA, USA). The sections were finally 
incubated with 3,3’-diaminobenzidine (DAB; Dako) for 10 minutes to develop color. The chondrocytes 
cultured in 24-well tissue culture plates were stained with the same protocols after reaching confluence by 
five days of culturing. The stained samples were observed under an optical microscope. 
3.3.11 Real-time PCR analysis 
Expression of genes encoding collagen type II, aggrecan, Sox 9 and collagen type I were analyzed by a 
real-time PCR.[25] The cell-laden hydrogel disk implants were washed with PBS three times, frozen in 
liquid nitrogen and crushed into powder by an electric crusher. The powder samples were dissolved in 
Sepasol solution (1 mL per sample; Nacalai tesque, Kyoto, Japan) to isolate the RNA. The RNA content in 
each sample was quantified, after which the RNA was converted to cDNA by MuLV reverse transcriptase 
(Applied Biosystems, Foster City, CA, USA). Real-time PCR was used to amplify 
glyceraldehyde-3-phosphate dehydrogenase (Gapdh), type II collagen (Col-II), aggrecan (Acan), Sox 9 and 
type I collagen (Col-I) by using a 7500 real-time PCR System (Applied Belgium, Foster City, CA, USA). 
The expression level of Gapdh, a housekeeping gene, was used as an endogenous control. The relative 
expression of the target gene was calculated by using the 2-ΔΔCT formula and passage 2 chondrocytes as a 
reference. The primer and probe sequences were the same as those used in the previous study. Four samples 
in each group were used for the measurement to calculate means and standard deviations. 
3.3.12 Statistical analysis 
All data were reported as the mean ± standard deviation (SD). Statistical analysis was performed using a 
one-way ANOVA analysis to evaluate the significance of the experimental data. Statistical differences were 
considered significant if p < 0.05. (*), (**) and (***) indicated p < 0.05, p < 0.01 and p < 0.001, respectively. 
All statistical analyses were executed by using KyPlot 2.0 beta 15 (1997–2001 Koichi Yoshioka). 
3.4 Results and discussion 
3.4.1 Synthesis and 1H NMR of GelMA and GelMAGMA macromers 
Gelatin has abundant amino, hydroxyl and carboxyl groups that can be used for modification. After the 
reaction of the amino groups in gelatin molecules with methacrylic anhydride, the remaining hydroxyl and 
carboxyl groups can be used for further modification in an acidic environment.[20] GelMA macromer was 
first synthesized, and then the GelMA macromer was used for the second modification to synthesize 
GelMAGMA. The 1H NMR spectra of GelMA and GelMAGMA macromers are shown in Figure 3.1a. The 
protons in methacrylate groups are indicated in the 1H NMR spectra. Integrated intensity of the protons in 
methacrylate groups of the GelMAGMA macromer (1.83) was much higher than that of the GelMA macromer 
(0.96). The result indicated that the methacrylate group density in the GelMAGMA macromer was higher than 
that in the GelMA macromer. The second modification by reaction between the hydroxyl and carboxyl 
groups with glycidyl methacrylate increased the photocrosslinkable double bonds in the GelMAGMA 
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macromer, which should result in high degree of cross-linking in the GelMAGMA hydrogels. The GelMA 
and GelMAGMA macromers were used to prepare gelatin hydrogels having respectively low and high 
densities of cross-linking. Chondrocytes were suspended in the macromer solution before UV irradiation to 
prepare cell-laden gelatin hydrogels (Figure 3.1b). 
  
Figure 3.1 1H NMR spectra of GelMA and GelMAGMA macromers (a). Experimental scheme of GelMA 
and GelMAGMA hydrogels encapsulated with chondrocytes and illustration of cell-laden hydrogel networks 
(b).  
3.4.2 Rheological property of GelMA and GelMAGMA hydrogels 
The GelMA solution became hydrogel at room temperature, while the GelMAGMA solution kept its 
solution state even at room temperature (Figure 3.2a), indicating a reduction of the intermolecular interaction 
forces of the gelatin chains by modification.[21] 
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The storage modulus (G’) of the GelMA and GelMAGMA hydrogels (10%, w/v) was measured at a 
constant deformation of 5% and a frequency of 1 Hz (Figure 3.2b). The storage modulus of the GelMAGMA 
hydrogel was significantly higher than that of the GelMA hydrogel. This should be due to high crosslinking 
density and steric hindrance between polymer chains in the GelMAGMA hydrogel. It has been reported that 
compressive modulus of a GelMA hydrogel increases with the degree of modification.[26] Hydrogels with 
different modification degrees and concentrations of GelMA have been reported to exhibit a broad range of 
compressive moduli from 3 to 30 kPa.[7] Hydrogels with 30 kPa Young’s modulus can be formed with 15% 
GelMA having a modification degree of 80%. In our previous study, the compressive modulus of GelMA 
hydrogel could be enhanced to 30 kPa by using 10% GelMA macromer having a modification degree of 
90%.[9] The GelMAGMA hydrogel in this study showed a higher storage modulus than did the GelMA 
hydrogel. The results indicated that the stiffness of gelatin-based hydrogel could be increased by sequential 
modification with methacrylic anhydride and glycidyl methacrylate without changing gelatin concentration. 
It has been reported that the different properties of crosslinked hydrogels, such as storage modulus, swelling 
ratio and degradation rate can be controlled by network crosslinking density.[14] It has also been reported 
that the mechanical property of GelMA hydrogel can be adjusted by modification degree or macromer 
concentration.[7,9] The sequential double modification of amino, hydroxyl and carboxyl groups in gelatin 
molecules was demonstrated as an efficient way to adjust the crosslinking density and Young’s modulus of 
gelatin hydrogels.  
 
Figure 3.2 Gross appearance of GelMA and GelMAGMA solution (10%, w/v) at room temperature (a). The 
storage modulus (G’) of GelMA and GelMAGMA hydrogels at 37 oC with a constant deformation of 5% and 
a frequency of 1 Hz (b). The data represent means ± SD, N=3. 
3.4.3 Swelling behavior and enzymatic degradation 
The swelling ratio of hydrogels is controlled by polymer network mesh size and polymer-solvent 
interaction. The swelling ratio of GelMAGMA hydrogel was slightly lower than that of GelMA hydrogel, 
although the difference was not significant (Figure 3.3a). The low swelling ratio of GelMAGMA hydrogel is 
most likely due to its high crosslinking density.  
Enzymatic degradation showed that the GelMAGMA hydrogel was more stable than the GelMA 
hydrogel (Figure 3.3b). The GelMA hydrogel was degraded rapidly by collagenase I. In contrast, the 
GelMAGMA hydrogels showed a very slow degradation rate. Gelatin hydrogels could be degraded by 
collagenase I easily while crosslinking inhibited its degradation. A higher crosslinking density led to a slower 
degradation rate. The slow degradation rate of GelMAGMA hydrogel should allow for long-term 
implantation. 
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Figure 3.3 Equilibrium swelling ratio of GelMA and GelMAGMA hydrogels (a), the data represent means ± 
SD, N=3. Enzymatic degradation of GelMA and GelMAGMA hydrogels in the presence of 10 unit mL-1 of 
collagenase type I at 37 oC with shaking (b), the data represent means ± SD, N=5.   
3.4.4 Cell viability in the hydrogels during in vitro culture 
Live/dead staining was used to evaluate cell viability in the two kinds of hydrogels immediately after 
UV crosslinking (Day 0) and after two weeks of in vitro culturing (Day 14) (Figure 3.4). A small number of 
chondrocytes were detected dead after UV-initiated polymerization. After culturing for two weeks, 
chondrocytes in all the groups showed high cell viability. Some chondrocytes integrated to form small 
aggregates. Chondrocytes in the GelMA and GelMAGMA hydrogels showed similar results. The results 
indicated that the UV-initiated polymerization of photocrosslinkable macromers did not evidently affect cell 
viability and that the GelMA and GelMAGMA hydrogels were compatible for chondrocyte culturing.  
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Figure 3.4 Live and dead staining of chondrocytes in GelMA and GelMAGMA hydrogels after UV 
crosslinking (Day 0) and after 14 days in vitro culturing (Day 14). Scale bar = 200 μm. (Green: live cells; 
Red: dead cells) 
3.4.5 DNA and sGAG quantification 
DNA amount and sGAG content in the cell-laden hydrogel disk implants at the beginning (week 0) and 
after six weeks implantation (week 6) were measured (Figure 3.5). After six weeks of implantation, the DNA 
amount decreased in both GelMA and GelMAGMA hydrogels. However, the sGAG content increased 
significantly after six weeks of implantation. sGAG is one of the main components of native cartilage and is 
used to evaluate chondrogenic activity.[27] The decrease of DNA amount might be due to partial cell death 
and limited nutrient diffusion and penetration in the hydrogels. Formation of cartilaginous matrices in 
hydrogel has been reported to hamper nutrient diffusion and therefore affect cell proliferation during long 
period implantation.[28] The high sGAG content indicated the hydrogels were beneficial for secretion of 
cartilaginous matrices, in particular, the GelMA hydrogel. 
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Figure 3.5 DNA amount (a) and sGAG content (b) in GelMA and GelMAGMA hydrogels before 
implantation (0 week) and after in vivo implantation for six weeks (6 week). Means ± SD, N=4. 
3.4.6 Histological and immunohistochemical stainings 
HE staining showed that chondrocytes in both GelMA and GelMAGMA hydrogels had round 
morphology that were similar to chondrocyte morphology in native cartilage (Figure 3.6). It has been 
reported that round cell morphology, possessing weak actin cytoskeletal organization, is beneficial for 
chondrogenesis.[29] Partial chondrocytes aggregated to form small aggregates. Cell aggregation has been 
reported to be good for chondrogenic ECM secretion and chondrocyte phenotype maintenance.[30,31] 
Safranin O and alcian blue staining results showed that cartilaginous matrices were detected around the 
round cells. Immunohistochemical staining of type II collagen also demonstrated the presence of type II 
collagen in areas surrounding the round cells. Both GelMA and GelMAGMA hydrogels showed slight 
staining of type I collagen. The chondrocytes in GelMA hydrogels showed slightly stronger staining of 
chondrogenic matrices than did the cells in GelMAGMA hydrogels. The high crosslinking density in 
GelMAGMA hydrogels might inhibit the diffusion of cartilaginous matrices. It has been reported that 
diffusion of ECM is related to the hydrogel network structure and diffusivity decreases when the crosslinking 
density increases.[32] 
To further compare the morphology and phenotype of chondrocytes in 2D and 3D, the same 
chondrocytes (passage 2) were cultured in cell culture plates for five days. The chondrocytes reached 
confluence after five days of culturing. The chondrocytes showed elongated morphology. Safranin O and 
alcian blue staining showed that no cartilaginous matrices were detected. Immunohistochemical staining of 
type I and type II collagen showed that type I collagen was detected while no type II collagen was detected. 
Many studies have reported that chondrocytes change their morphology from round to spindle-like elongated 
shape and lose the capacity to express cartilaginous matrices during 2D expansion culturing.[33-35] 
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Figure 3.6 Hematoxylin and eosin (HE), safranin O (Saf-O) and alcian blue staining and 
immunohistochemical staining of collagen type II (Col-II) and collagen type I (Col-I) of the GelMA and 
GelMAGMA hydrogel implants after subcutaneous implantation for six weeks. Chondrocytes cultured in 
24-well tissue culture plates (TCP) for five days were stained as a control. Scale bar = 200 μm. 
3.4.7 Cartilaginous gene expression 
To further compare the influence of GelMA and GelMAGMA hydrogels on chondrocyte phenotype, 
gene expression of aggrecan (Figure 3.7a), collagen type II (Figure 3.7b), Sox9 (Figure 3.7c) and collagen 
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type I (Figure 3.7d) were investigated by real-time PCR. Collagen type II and aggrecan are the two main 
characteristic genes related to chondrogenic differentiation.[36] Sox9 is the key transcription factor of 
chondrogenesis and chondrogenic differentiation.[37] The expression level of collagen type II, aggrecan and 
Sox9 was significantly higher than that of chondrocytes used for cell seeding, while there was no significant 
difference in expression of collagen type I. The results indicated that culturing in the hydrogels up-regulated 
cartilaginous gene expression. The hydrogels could provide a 3D microenvironment for expression of 
cartilaginous genes. The expression level of the cartilaginous genes in the GelMA hydrogel was significantly 
higher than that in the GelMAGMA hydrogel. 
  
Figure 3.7 Expression of genes encoding aggrecan (a), collagen II (b), Sox 9 (c) and collagen I (d) of 
chondrocytes in GelMA and GelMAGMA hydrogel implants after six weeks of implantation. Data 
represent means ± SD, N=3. 
In this study, two types of gelatin hydrogels were prepared by modifying the amino, hydroxyl and 
carboxyl groups in gelatin molecules with photocrosslinkable methacrylate groups. The first modification 
was conducted by reacting amino groups in gelatin molecules with methacrylic anhydride. The second 
modification was carried out by coupling the hydroxyl and carboxyl groups with glycidyl methacrylate. After 
double modification, more methacrylate groups were introduced in gelatin molecules. The hydrogels 
prepared from the double modified GelMAGMA macromer had higher crosslinking density and storage 
modulus than did the hydrogels prepared from single modified GelMA macromer. The GelMAGMA 
hydrogel was degraded more slowly than the GelMA hydrogel. By using the sequential double modification, 
gelatin hydrogels with a broad difference of storage modulus could be prepared.  
Many methods have been reported to modulate the mechanical properties of gelatin hydrogels, 
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including the incorporation of nanoparticles, hybridization with other polymers, UV irradiation dosage and 
modification degree.[38,39] The previous two methods may induce other components in the hydrogels. High 
dosage and long UV irradiation may induce cellular damage. Modification degree can be modulated by 
binding a different amount of methacrylate groups with the amino groups in gelatin molecules. However, the 
range of mechanical properties that can be tuned by methacrylation of amino groups is limited. The 
sequential double modification of the amino, hydroxyl and carboxyl groups in gelatin broadened the tunable 
modification degree and mechanical property range. There are many crosslinking methods that can be used 
to prepare gelatin hydrogels and scaffolds for biomedical applications.[40-43] Crosslinking reagents, such as 
carbodiimides and succinimides,[43] glutaraldehyde,[44] and genipin,[45] and high energy irradiation,[46] 
have been used for the crosslinking. However, these methods should be used to crosslink the hydrogels and 
scaffolds before cell-lading to avoid cytotoxicity. In this study, UV-initiated polymerization was used to 
crosslink the GelMA and GelMAGMA macromers and had no evident negative influence on cell viability. 
Both GelMA and GelMAGMA hydrogels showed promotive effects for chondrocytes to keep round 
morphology and express cartilaginous matrices. However, the hydrogels hampered cell proliferation. The 
effects should be due to the 3D microenvironment in hydrogels that are beneficial for chondrogenic 
differentiation, rather than cell proliferation. By comparison of the two gelatin hydrogels with low and high 
storage modulus, the GelMA hydrogel (low storage modulus) was more beneficial to cartilaginous matrices 
expression than the GelMAGMA hydrogel (high storage modulus). Physical cues, such as stiffness and cell 
size have been reported to have influences on cell functions.[47,48] In our previous study, gelatin hydrogel 
with the highest stiffness showed the best effects on maintaining the phenotype of chondrocytes. The gelatin 
hydrogel with the highest stiffness in the previous study was the GelMA hydrogel in this study. Further 
increasing the stiffness and storage modulus had no effect on the promotion of expression of cartilaginous 
matrices, nor the maintenance of chondrogenic phenotype. It has been reported that 
gelatin-hydroxyphenylpropionic acid hydrogel with a storage modulus of 1000 Pa has the best function for 
cartilage regeneration. Therefore, the GelMA hydrogel should provide the optimal microenvironment for 
maintenance of chondrocyte phenotypes. Influence of the second modification on the bioactive groups, such 
as the RGD motif in gelatin molecules might be another reason for the different effect on chondrocyte 
functions, which needs confirmation in the future. The good mechanical property and slow degradation of 
the GelMAGMA hydrogel should provide a variety of opportunities for incorporation of other bioactive 
factors or introduction of microporous structures in the hydrogels for cartilage tissue engineering. 
3.5 Conclusions 
Gelatin macromer with a high degree of modification was synthesized by sequential double 
modification of amino, hydroxyl and carboxyl groups in gelatin molecules. The double modified 
GelMAGMA macromer was used to prepare chondrocyte-laden hydrogel for 3D culturing of chondrocytes. 
The GelMAGMA hydrogel had a higher storage modulus and slower enzymatic degradation than did the 
hydrogel prepared with single modified GelMA macromer. The GelMAGMA hydrogel facilitated expression 
of cartilaginous matrices, as well as the maintenance of cartilage phenotype, while hampering cell 
proliferation. The GelMAGMA hydrogel should be useful for strengthening hydrogel scaffolds with a low 
degradation rate for cartilage tissue engineering. 
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Chapter 4 
Influence of microporous gelatin hydrogels on chondrocyte 
functions  
 
 
 
 
4.1 Summary 
Hydrogels can provide biomimetic three-dimensional microenvironments for transplanted cells and are 
attractive scaffolds for cartilage tissue engineering. In this part, gelatin hydrogels with microporous 
structures were prepared and their effects on chondrocyte functions were compared with gelatin hydrogels 
without microporous structures. Gelatin bulk hydrogels were prepared by photo-initiated crosslinking of 
gelatin methacrylate macromers. Micropores were formed in the bulk hydrogels by dissolution of gelatin 
microgels prepared by a cutting method. Chondrocytes cultured in gelatin hydrogels without microporous 
structures showed high expression and production of cartilaginous matrices while low cell proliferation. 
Chondrocytes cultured in gelatin hydrogels with microporous structures tended to migrate from bulk 
hydrogel matrices to the micropores. Chondrocytes in the microporous hydrogels showed higher 
proliferation while lower expression and production of cartilaginous matrices than did the chondrocytes 
cultured in hydrogels without microporous structures. Gelatin hydrogels without microporous structures 
facilitated maintenance of cartilaginous phenotype of chondrocytes while microporous gelatin hydrogels 
were beneficial for cell proliferation.   
4.2 Introduction 
Cartilage tissue engineering has been developed as a useful approach for repairing of articular cartilage 
defects because articular cartilage has very limited regenerative capacity.[1-3] Tissue engineering approach 
usually combines cells, scaffolds and bioactive factors to induce regeneration of functional cartilage.[4-6] 
Scaffolds serve as a temporary support to accommodate cells and provide various signals for cell adhesion, 
proliferation, differentiation and secretion of extracellular matrices. A number of scaffolds have been 
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prepared from biodegradable polymers for cartilage tissue engineering.[7-10] Generally, biodegradable 
polymers are processed to form porous sponges or fabric scaffolds or hydrogels for applications in cartilage 
tissue engineering. 
Although porous sponges or fabric scaffolds can provide plenty of vacant space to accommodate the 
transplanted cells, hydrogels have drawn extensive attention for cartilage tissue engineering due to their 
structural similarity to the microenvironments surrounding chondrocytes in vivo.[11-16] In cartilage tissue, 
chondrocytes are embedded in cartilaginous hydrogel-like matrices.[17] Hydrogels are physically or 
chemically crosslinked polymer networks that absorb plenty of water and swell in aqueous solution. 
Hydrogels have many advantages because they can provide a three-dimensional microenvironment by 
encapsulation of transplanted cells in the hydrogel matrices and can be delivered to defects by low-invasive 
injection. In hydrogels, transplanted cells are encapsulated in the hydrogel matrices that can provide similar 
in vivo microenvironments for cell differentiation and maintenance of phenotype.[18-21] Culture in 
hydrogels has been applied for chondrogenic differentiation of stem cells, such as bone-marrow derived 
mesenchymal stem cells and adipose derived mesenchymal stem cells. [19,20] They have also been used to 
maintain the phenotype of chondrocytes.[21] Hydrogels have shown better effects on chondrogenic 
differentiation than do porous sponges or fabric scaffolds. On the other hand, proliferation to obtain 
sufficient cell number is critical for cartilage tissue engineering because of the limited cell number from 
patients. Except for cell differentiation and maintenance of cell phenotype, hydrogels should provide 
favorable microenvironments to promote cell proliferation.  
Introduction of micropores has been adopted to improve the microporous structures of hydrogels for 
accelerating cell proliferation.[22,23] To prepare microporous structures in hydrogels, gelatin, alginate and 
hyaluronic acid are usually used as porogen materials because they can be easily dissolved or degraded by 
thermal (body temperature), chemical or enzymatic treatments.[11] They have been used to prepare porous 
hydrogels of alginate, gelatin and fibrin.[23-26] The microporous structures promote cell migration, adhesion 
and proliferation. However, the porogen materials used to introduce microporous structures in hydrogels are 
usually different with the materials of the bulk hydrogel.[27] Although the porogen-forming materials are 
dissolved or degraded, most of them or their by-products are remained in the micropores and are gradually 
diffused through the bulk hydrogel matrices.[28] The micropores still contain some of the porogen-forming 
materials, which results in different microenvironments in the micropores and bulk hydrogel. To elucidate 
the effect of microstructures, the same porogen materials and bulk hydrogel matrices are desirable to 
eliminate the effect from the material difference.  
Therefore, in this study, the same gelatin material was used for micropore formation and for bulk 
hydrogel preparation. Gelatin was used because gelatin has sol-gel translation temperature lower than body 
temperature and gelatin can be crosslinked by UV irradiation after methacrylation. Gelatin is also 
biocompatible and has been broadly used for cartilage tissue engineering. Gelatin microgels with microcubic 
shapes were prepared by a cutting method. Gelatin was sequentially modified with methacrylic anhydride 
and glycidyl methacrylate to prepare photocrosslinkable gelatin macromers. The gelatin microgels and 
photocrosslinkable gelatin macromers were mixed to prepare gelatin hydrogels with microporous structures. 
Gelatin hydrogels without microporous structures were used as a control. The behaviors of chondrocytes in 
the gelatin hydrogels with or without micropores were compared to disclose the effects of microporous 
structures on the chondrocyte functions. 
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4.3 Materials and methods 
4.3.1 Synthesis of methacrylated gelatin macromers 
Gelatin methacryloyl (GelMA) macromer was first synthesized according to a previously described 
method (Figure 4.1a).[29] Briefly, 5 g gelatin (type A, 300 bloom, Sigma-Aldrich, St. Louis, MO, USA) was 
dissolved in 50 mL phosphate buffered saline (PBS) at 60 oC under stirring to obtain a 10% (w/v) gelatin 
solution. 5 mL methacrylic anhydride (MA, Sigma-Aldrich, USA) was added into the gelatin solution at a 
rate of 0.5 mL/minutes under stirring at 50 oC. After the reaction was performed in dark for 3 hours, the 
resulting solution was diluted with 5-fold warm PBS (50 oC) and then was dialyzed against Milli-Q water at 
40 oC for 7 days using a dialysis membrane (12-14 kD molecular weight cut-off, Spectrum Laboratories Inc. 
USA) to remove salts and excess free MA. After dialysis, GelMA macromer was obtained. The GelMA 
macromer was further modified with glycidyl methacrylate to prepare glycidyl methacrylate-modified 
GelMA (GelMAGMA macromer) by the following procedures (Figure 4.1a). The pH of GelMA macromer 
solution was adjusted to 3.5 and then 10 mL glycidyl methacrylate was added into the solution.[30] The 
reaction was conducted at 50 oC for 24 hours and then the product was dialyzed against milliQ water by the 
above-mentioned dialysis membrane at 40 oC for 7 days. The final products were lyophilized to obtain white 
foam and stored at -20 oC for further use. 
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Figure 4.1 Preparation scheme of GelMAGMA macromers (a), mesh-cutted gelatin microgels (b) and 
GelMAGMA hydrogels with or without microporous structures (c). 
4.3.2 1H nuclear magnetic resonance (NMR) 
The degree of functionalization (DoF) of GelMA and GelMAGMA macromers were studied by using 
1H NMR according to a previously described method.[31] 1H NMR spectra were collected by using a Varian 
INOVA NMR spectrometer with a single axis gradient inverse probe at a frequency of 300 MHz. Before the 
measurement, 20 mg of GelMA and GelMAGMA macromers were respectively dissolved into 1 mL 
deuterium oxide containing 0.05% (w/v) 3-(trimethylsilyl)propionic-2,2,3,3-d4 acid sodium salt 
(Sigma-Aldrich, USA). The pristine gelatin without functionalization was also examined as a control. 
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4.3.3 Sol-gel translation property 
MCR301 Rheometer (Anton Paar, Germany) was used to determine the rheological property of pristine 
gelatin, GelMA and GelMAGMA solutions (10% (w/v)). The solution was obtained by dissolving the 
powder or white foam into PBS at 50 oC. 300 µL of each sample was used for the measurement. Oscillatory 
dynamic measurement was chosen using a parallel plate with the PP-50. Temperature sweep (from 37 oC to 
20 oC, cooling rate was 0.15 oC min-1) was performed at a fixed amplitude (γ = 5%) and frequency (1 Hz). 
The sol-gel transition temperature was determined by the cross point of storage moduli (G’) and loss moduli 
(G’’).[31] 
4.3.4 Chondrocytes isolation and subculture 
Bovine articular chondrocytes (BACs) were isolated from articular cartilage from the knees of a 9 
week-old calf according to previously reported protocol.[10] The isolated primary chondrocytes were 
cultured in 75 cm2 tissue culture flasks in Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 
10% fetal bovine serum, 4500 mg L-1 glucose, 4 mM glutamine, 100 U mL-1 penicillin, 100 µg mL-1 
streptomycin, 0.1 mM nonessential amino acids, 0.4 mM proline, 1 mM sodium pyruvate and 50 µg mL-1 
ascorbic acid at 37 oC and 5% CO2. The cell culture medium was refreshed every 3 days. The cells were 
subcultured after reaching confluence. Chondrocytes at passage 2 (P2) were used in the following 
experiments. Chondrocytes were detached with a trypsin/EDTA solution and collected by centrifugation. The 
chondrocytes were re-suspended in gelatin solution or GelMAGMA macromer solution in the following 
experiments. 
4.3.5 Preparation of gelatin microcubes 
Gelatin microgels with microcubic shapes were prepared by using a mesh-cutting method (Figure 4.1b). 
Gelatin solution (5% w/v) was prepared by dissolving pristine gelatin powder (type A, 175 bloom, 
Sigma-Aldrich) in a mixed solution that was prepared by mixing PBS and cell culture medium at a (v/v) ratio 
of 1:1. The gelatin solution was sterilized by filtration through a 0.22 µm filter. The sterilized gelatin solution 
was mixed with chondrocytes to prepare cell suspension solution at a cell concentration of 4 × 107 cells/mL. 
The cell suspension solution was poured into a sterile silicone frame having a space size of 100 mm × 20 mm 
× 300 µm that was placed on a sterile cover glass at 37 oC. A sterile cover glass was placed on the silicone 
frame to control the thickness of solution. The glass plate/cell solution constructs were put in a 4 oC 
refrigerator for 0.5 hour to allow gelation of cell suspension solution. The cell-laden gelatin hydrogel sheet 
was detached from the silicone frame and cover glasses and extended on a sterile nylon mesh having a mesh 
size of 250 µm × 250 µm (AS ONE, Japan). The cell-laden gelatin hydrogel sheet was gently pressed by a 
sterile spatula to pass through the nylon mesh. After the cell-laden gelatin hydrogel sheet was cut by the 
nylon mesh, cell-laden gelatin microgels having microcubic shapes were obtained. The cell-laden gelatin 
hydrogel microcubes were washed away from the mesh with sterile PBS and collected in 50 mL centrifuge 
tubes by centrifugation at 2000 rpm at 4 oC. All the procedures were operated at sterile conditions. Gelatin 
hydrogel microcubes without chondrocytes were also prepared by the same procedures as described above 
by using gelatin solution without cells. The cell-laden gelatin hydrogel microcubes and pure gelatin hydrogel 
microcubes were used for following experiments. 
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4.3.6 Preparation of cell-laden GelMAGMA hydrogels without microporous structures 
The GelMAGMA macromers were dissolved in PBS at 50 oC to prepare macromer aqueous solution at a 
concentration of 10 (w/v) %. Photo-initiator, 2-hydroxy-1-(4-(hydroxyethoxy) 
phenyl)-2-methyl-1-propanone (I 2959, Sigma-Aldrich, USA), was dissolved in the macromer aqueous 
solution at a concentration of 0.5 (w/v) % at 50 oC. The mixture solution was sterilized by filtration through a 
0.22 µm filter and cooled down to room temperature. The sterilized mixture solution was mixed with the 
chondrocytes to prepare cell suspension solution in the GelMAGMA/photo-initiator mixture solution at a cell 
concentration of 2 × 107 cells/mL. The cell suspension solution was put between two quartz coverslips 
separated by a 1.5 mm-thick silicone spacer (KOKEN Co., Ltd., Tokyo, Japan) and exposed to UV light 
(CL-1000, Funakoshi Co., Ltd., Japan) at a distance of 20 cm for 5 minutes. After photo-initiated gelation, 
the cell-laden GelMAGMA hydrogels were punched into disks by a 6-mm biopsy punch (Group A in Figure 
4.1c). The hydrogel disks had a diameter of 6 mm and a height of 1.5 mm. All the procedures were 
conducted under sterile conditions at room temperature. The cell-laden GelMAGMA hydrogel disks without 
gelatin hydrogel microcubes were put in T-flasks and cultured in DMEM at an atmosphere of 5% CO2 at 37 
oC with shaking. 
4.3.7 Preparation of cell-laden GelMAGMA hydrogels with microporous structures 
The above-prepared cell suspension solution in the GelMAGMA/photo-initiator mixture solution was 
added with pure gelatin hydrogel microcubes or cell-free GelMAGMA/photo-initiator mixture solution was 
added with cell-laden gelatin hydrogel microcubes at a mixture ratio of hydrogel microcubes and solution of 
1: 2 (w/v) (Group B and C in Figure 4.1c). The mixture solution was put between the quartz coverslips, 
exposed to UV light and punched into disks having a diameter of 6 mm as above mentioned. The hydrogel 
disks were put in T-flasks and cultured in DMEM at an atmosphere of 5% CO2 at 37 oC with shaking. They 
were cultured for 28 days and medium was changed every two days. All the procedures were conducted 
under sterile conditions at room temperature. 
4.3.8 Cell viability assay 
Live/dead staining was performed to evaluate in vitro cell viability of chondrocytes in the hydrogels by 
using Cellstain Double Staining Kit (Dojindo Laboratories, Tokyo, Japan). After UV crosslinking and 28 
days of in vitro culture, the cell-laden GelMAGMA hydrogel disks with or without gelatin hydrogel 
microcubes were washed with PBS for three times and incubated with serum-free medium containing 
calcein-AM (2 µM) and propidium iodide (4 µM) at 37 oC for 15 minutes. The stained cells were observed 
using a confocal microscope (Zeiss LSM 510 Meta). 
4.3.9 In vivo implantation 
The animal experiment was approved by the animal experiments committee of the National Institute for 
Materials Science. All mice were maintained with a standard laboratory diet and water ad libitum. 4-week 
old athymic nude mice were used and all the operation of animal experiment was conducted according to the 
committee guidelines of the National Institute for Materials Science for Animal Experiments. After the 
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cell-laden GelMAGMA hydrogel disks with or without gelatin hydrogel microcubes were cultured in DMEM 
under an atmosphere of 5% CO2 at 37 oC with shaking for 1 day, the hydrogel disks (6 mm diameter × 1.5 
mm height) were subcutaneously implanted into the dorsa of nude mice. Every mouse was implanted with 
four samples. After 12 weeks of implantation, the mice were euthanized and the samples were harvested for 
further investigation. The gross appearance of the implants was recorded using a digital camera. 
4.3.10 Histological and immunohistochemical staining 
After 12 weeks of implantation, the implants were carefully separated from the mice tissue, washed 
with PBS for three times and fixed with 10% neutral buffer formalin at room temperature for 2 days. The 
samples were dehydrated in a series of ethanol solution with increasing ethanol concentration from 70% to 
99.5%, embedded in paraffin and sectioned to obtain cross-sections having 7 µm thickness. The 
cross-sections were deparaffinized, stained with hematoxylin and eosin (HE staining) for cell morphology 
and stained with alcian blue for glycosaminoglycan. Immunohistochemical staining of collagen type II was 
performed according to a previous report.[6] Briefly, the deparaffinized sections were incubated with 
proteinase K for 10 minutes for antigen retrieval and then incubated with peroxidase blocking solution for 5 
minutes and 10% goat serum solution for 30 minutes. The sections were next incubated with the first 
antibody for 2 hours at room temperature, followed by incubation with the peroxidase labeled 
polymer-conjugated second antibody (DakoCytomation Envision+, Dako, Carpinteria, CA) for 30 minutes. 
The first antibody was rabbit polyclonal anti-bovine collagen type II at a 1:100 working dilution (Thermo 
Scientific, Rockford, IL). The sections were finally incubated with 3,3’-diaminobenzidine (DAB) for 10 
minutes to develop color. The stained samples were observed under an optical microscope. 
4.3.11 Quantification of DNA and sulfated glycosaminoglycan (sGAG) 
DNA amount of cells in the hydrogels was quantified to evaluate the proliferation of chondrocytes. The 
cell-laden GelMAGMA hydrogels after in vitro culture for 2 and 4 weeks and after 12 weeks implantation 
were harvested, washed with PBS for three times and freeze-dried. The freeze-dried hydrogels and implants 
were digested by 500 µL papain solution (Sigma-Aldrich, USA), which was prepared by dissolving papain at 
a concentration of 400 mg/mL in 0.1 M PBS (pH 6.0) containing 5 mM cysteine hydrochloride and 5 mM 
ethylenediaminetetraacetic acid (EDTA). 5 µL of papain digestion solution was used to measure the DNA 
content with Hoechst 33258 dye (Sigma-Aldrich, USA). The fluorescence intensity was read with an 
FP-6500 spectrofluorometer (JASCO, Tokyo, Japan) at an excitation/emission wavelength of 360 nm and 
460 nm. The sGAG content in each digestion solution was measured by using BlyscanTM 
Glycosaminoglycan Assay Kit (Biocolor Ltd., County Antrim, UK) according to the instructions offered by 
the products. Three samples in each group were used for the measurement to calculate means and standard 
deviations. 
4.3.12 Real-time PCR analysis 
Expression of genes encoding collagen type II and aggrecan genes was analyzed by a real-time 
polymerase chain reaction (PCR).[6] The implants after 12 weeks of implantation were harvested, washed 
with PBS for three times, frozen in liquid nitrogen and crushed into powder by an electric crusher. The 
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powder samples were dissolved in Sepasol solution (1 mL per sample) to isolate the RNA. The RNA content 
in each sample was quantified and then the RNA was converted to cDNA by MuLV reverse transcriptase 
(Applied Biosystems, USA). Real-time PCR was used to amplify glyceraldehyde-3-phosphate 
dehydrogenase (Gapdh), type II collagen (Col2a1) and aggrecan (Acan) by using a 7500 real-time PCR 
System (Applied Belgium, USA). The expression level of Gapdh, a housekeeping gene, was used as an 
endogenous control. The relative expression level of each target gene was calculated by using 2-ΔΔCt formula 
and P2 chondrocytes as a reference. The primer and probe sequences were the same as the previous 
study.[10] Three samples in each group were used for the measurement to calculate means and standard 
deviations. 
4.3.13 Statistical analysis 
All data were reported as the mean ± standard deviation (SD). Statistical analysis was performed using a 
one-way analysis of variance and Tukey's post hoc test for multiple comparisons. All statistical analyses were 
executed by using KyPlot 2.0 beta 15. 
4.4 Results and discussion 
4.4.1 Synthesis and characterization of double modified gelatin macromer  
GelMA macromer was synthesized by forming covalent bonds between the amino groups in gelatin 
molecules and methacrylic anhydride.[29] The GelMA macromer was further reacted with glycidyl 
methacrylate to synthesize GelMAGMA macromer (Figure 4.1a). The reaction was performed under acid 
condition (pH = 3.5) because it has been reported that the carboxyl and hydroxyl groups rather than amino 
groups react with glycidyl methacrylate through ring opening mechanism at acid environment.[30] The 
introduction of methacrylate groups in GelMA and GelMAGMA macromers was confirmed by 1H NMR. 
The two obvious peaks at 5.4 and 5.7 ppm that were assigned to the vinyl protons of methacrylate groups 
were observed in the 1H NMR spectrum of GelMA macromer. Furthermore, the peak intensity at δ = 2.9 ppm 
that was assigned to the N-methylene protons in lysine groups decreased after reaction with methacrylic 
anhydride. After the second modification with glycidyl methacrylate, the peaks assigned to the vinyl protons 
of glycidyl methacrylate were observed at 5.8 and 6.2 ppm in the 1H NMR of GelMAGMA macromer. The 
integrated intensity of the four peaks at 5.4, 5.7, 5.8 and 6.2 ppm in the 1H NMR spectrum of the 
GelMAGMA macromer was almost two folds than that of the two peaks at 5.4 and 5.7 ppm in the 1H NMR 
spectrum of GelMA macromer (Figure 4.2a). The results indicated the successful introduction of 
methacrylate and glycidyl methacrylate groups in the GelMAGMA macromer. In general, modification of 
gelatin with methacrylic anhydride or glycidyl methacrylate has been used for the preparation of gelatin 
hydrogels. In this study, methacrylic anhydride was used to react with amine groups in gelatin for first 
modification, and glycidyl methacrylate was used for second modification of carboxyl and hydroxyl groups 
in gelatin. The double modified gelatin should generate more crosslinkages during UV-initiated crosslinking 
reaction to form more stable hydrogels than the single modified gelatin macromers. 
The rheological property of pristine gelatin, GelMA and GelMAGMA solution was investigated by 
oscillatory dynamic measurement. The G’ and G’’ of gelatin, GelMA and GelMAGMA solution at a 
concentration of 10 (w/v) % changed with temperature (Figure 4.2b). The sol-gel translation temperature was 
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measured from the cross point of G’ exceeding G’’.[31,32] The sol-gel translation temperature of pristine 
gelatin, GelMA and GelMAGMA was 36.0, 31.9 and 22.7 oC, respectively. The sol-gel translation 
temperature of GelMAGMA macromer was lower than room temperature. The decrease of sol-gel translation 
temperature of GelMA macromer should be due to a decrease of hydrogen atoms in amine groups and steric 
hindrance of methacrylate groups in GelMA for hydrogen bonding. Double modified GelMAGMA 
macromers further decreased the number of hydroxyl groups and carboxyl groups for hydrogen 
bonding.[31,33,34] The low translation temperature could maintain the GelMAGMA aqueous solution at a 
solution state at room temperature, which should allow easy cell suspension and incorporation of other 
materials, such as nano and micro particles in GelMAGMA macromer aqueous solution without heating. 
 
Figure 4.2 1H NMR spectra of pristine gelatin, GelMA and GelMAGMA macromers (a) and 
temperature-dependence curves of G’ and G’’ value of pristine gelatin, GelMA and GelMAGMA solution 
(10 %, w/v) (b). 
4.4.2 Preparation of cell-laden GelMAGMA hydrogels with or without microporous 
structures 
The GelMAGMA macromer was used to prepare hydrogels for 3D culture of chondrocytes. To 
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introduce microporous structure in the hydrogels, gelatin hydrogel microcubes were used because gelatin 
hydrogel microcubes could be prepared at a low temperature, such as 4 oC and dissolved at high temperature, 
such as 37 oC. The gelatin hydrogel microcubes were prepared by cutting gelatin hydrogel sheets with a 
nylon mesh (Figure 4.1b). The cutting method could avoid usage of cell-unfriendly organic solvents or edible 
oils that are usually used to prepare gelatin microbeads.[25] Preparation of gelatin hydrogel microcubes 
without usage of organic solvents or oils should be an attractive advantage of the method. Pure gelatin 
hydrogel microcubes and cell-laden gelatin hydrogel microcubes were prepared by the method and 
incorporated in the GelMAGMA hydrogels. The hydrogel microcubes with or without cells laden had the 
same dimension that was around 250 × 250 × 300 µm (Figure 4.3a).  
 
Figure 4.3 Photomicrographs of gelatin microgels prepared by a mesh-cutting method (a) and cell-laden 
GelMAGMA hydrogel without microporous structures (Group A), cell-laden GelMAGMA hydrogel with 
microporous structures where cells were seed in bulk hydrogel (Group B) or in micropores (Group C) (b). 
High magnification photomicrographs of Group A, B and C hydrogels after 7 days in vitro culture (c). Scale 
bar: 200 µm. 
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The cell-laden GelMAGMA hydrogels were prepared by using GelMAGMA macromer. GelMAGMA 
macromer was dissolved in PBS and the solution was mixed with chondrocytes. Furthermore, the gelatin 
hydrogel microcubes with or without chondrocytes were added to the mixture solution. The mixtures were 
irradiated by UV light to initiate crosslinking reaction to prepare GelMAGMA hydrogels. After crosslinking 
reaction, cell-laden GelMAGMA hydrogels were prepared. Three types of cell-laden GelMAGMA hydrogels 
were prepared by changing the preparation conditions (Table 4.1, Figure 4.1c). Group A was prepared from 
chondrocytes/GelMAGMA mixture solution without gelatin hydrogel microcubes. Group B was prepared 
from chondrocytes/GelMAGMA mixture solution with pure gelatin hydrogel microcubes. Group C was 
prepared from GelMAGMA solution with cell-laden gelatin hydrogel microcubes. All the three types of 
hydrogels were prepared from the same concentration of GelMAGMA macromer and had the same number 
of chondrocytes. The cell-laden GelMAGMA hydrogels were punched into hydrogel disks. The hydrogel 
disks had the same transparent gross appearance (Figure 4.3b). 
 
The cell-laden GelMAGMA hydrogel disks were cultured in cell culture medium at 37 oC. After culture 
for 7 days, they were observed by optical microscopy (Figure. 4.3c). Group A showed homogeneous 
hydrogel structure without any micropores available (Figure 4.3c). The cells were distributed homogeneously 
in the hydrogel matrices. Groups B and C had micropores in the hydrogels. Formation of the micropores in 
the hydrogels should be due to the dissolution of gelatin hydrogel microcubes at 37 oC. Cell aggregates were 
observed at the peripheral edges of micropores in Group B. Cells showed even distribution in the micropores 
in Group C. The results indicated that chondrocytes in GelMAGMA hydrogel could migrate from hydrogel 
matrices to the micropores and predominately adhered and spread at the interface of micropores and medium 
(Group B). Chondrocytes seeded in the micropores did not migrate to the GelMAGMA hydrogel matrices 
(Group C). 
Table 4.1 Preparation conditions of Group A, B and C hydrogels 
 
Group A B C 
GelMAGMA 
solution 
2 mL 
(4 × 107 cells) 
2 mL 
(4 × 107 cells) 
2 mL 
(no cell) 
Microgel  
1 g 
(no cell) 
1 g 
(4 × 107 cells) 
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4.4.3 Cell viability and proliferation in GelMAGMA hydrogels during in vitro culture 
 
Figure 4.4 Live and dead staining of chondrocytes in the hydrogels immediately after UV crosslinking (0 
week) and after 28 days in vitro culture (4 weeks). Scale bar: 200 µm. 
 
After four weeks of in vitro culture, no obvious degradation or deformation of GelMAGMA hydrogel 
disks was observed in any of the three groups. Cell distribution and viability in the GelMAGMA hydrogels 
immediately after UV crosslinking and after 4 weeks culture were examined by live/dead staining (Figure 
4.4). After UV crosslinking (day 0), only a very small amount of dead cells (stained red) were observed in 
Group A and B. Few dead cells were observed in Group C. The results suggested that UV crosslinking 
process did not have an obvious effect on cell viability. Cells were distributed homogeneously in Group A. In 
Group B, cells in the crosslinked GelMAGMA bulk hydrogel matrices showed homogeneous distribution 
while no cells were detected in the pure gelatin hydrogel microcubes. In Group C, cells were homogeneously 
distributed only in the cell-laden gelatin hydrogel microcubes while no cells were detected in the crosslinked 
GelMAGMA bulk hydrogel matrices, which was opposite to that in Group B. Homogeneous cell distribution 
in Group A should be due to the even suspension of chondrocytes in the GelMAGMA solution before UV 
irradiation. Cells were only observed in the crosslinked GelMAGMA bulk hydrogel matrices in Group B 
because cells were only suspended in the GelMAGMA solution and cell-free gelatin hydrogel microcubes 
were used for the preparation of Group B. Cells were only observed in the gelatin hydrogel microcubes in 
Group C was because cell-laden gelatin hydrogel microcubes and cell-free GelMAGMA solution were used. 
The gelatin hydrogel microcubes maintained their cubic shape immediately after UV crosslinking reaction 
and then were gradually dissolved during cell culture.  
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After in vitro culture for 4 weeks, chondrocytes in all the groups showed high cell viability. Cell 
distribution was different from that at the beginning. Cell aggregates were observed in all the three groups 
and cell aggregates were larger in Group B and C than those in Group A. Cell density seemed less dense than 
that at the beginning, which should be due to cell aggregation. Cells were still homogeneously distributed in 
Group A and cell aggregates were small. However, cell distribution in Group B and C showed obvious 
change compared to that observed at the beginning. In Group B, big cell aggregates were observed in the 
micropores while relatively homogeneous cell distribution was observed in the GelMAGMA bulk hydrogel 
matrices. In Group C, big cell aggregates were observed in the micropores while no cells were observed in 
the GelMAGMA bulk hydrogel matrices. The results indicated that some of the cells seeded in the 
GelMAGMA bulk hydrogel migrated to the micropores and proliferated to form big aggregates in Group B. 
The cells seeded in the micropores in Group C resided in the micropores and proliferated to form big 
aggregates without migration to the GelMAGMA bulk hydrogel matrices.  
 
Figure 4.5 Quantification of DNA amount in the Group A, B and C hydrogels during in vitro culture. The 
data were normalized with dry weight of the hydrogels. Means ± SD, N=3. *, p < 0.05; and **, p < 0.01. 
 
Quantification of DNA amount showed that DNA amount in Group A during 4 weeks in vitro culture 
did not change (Figure 4.5). DNA amount in Group B and C increased during the first 2 weeks of in vitro 
culture and did not change (Group B) or decreased a little (Group C) during the next 2 weeks of in vitro 
culture. The results indicated that chondrocytes in the GelMAGMA bulk hydrogel had high viability but did 
no proliferate. Increase of DNA amount in Group B for the first 2 weeks should be due to the proliferation of 
migrated chondrocytes in the micropores. The micropores formed from dissolution of gelatin hydrogel 
microcubes allowed the adhesion and proliferation of migrated chondrocytes. The micropores in Group B 
and C provided vacant spaces for cell proliferation at the first two weeks. Nutrient diffusion limitation of the 
GelMAGMA bulk after 2 weeks culture might hamper further cell proliferation. 
4.4.4 Histological and immunohistochemical staining of in vivo implants 
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The GelMAGMA hydrogel disks were implanted subcutaneously in nude mice for 12 weeks. All the 
implants showed glistening white gross appearance (Figure 4.6a). The GelMAGMA hydrogel implants with 
microporous structures (Groups B and C) were slightly smaller than the GelMAGMA hydrogel implants 
without microporous structures, which indicated slight shrinkage of the GelMAGMA hydrogel implants with 
microporous structures. The shrinkage should be due to the microporous structures and cell-induced 
shrinkage in the hydrogels.[35] 
Cell morphology, distribution and extracellular matrices (ECMs) in the implants were examined by 
histological and immunohistochemical staining (Figure 4.6b). HE staining showed that chondrocytes in 
Group A had round morphology and distributed homogeneously in the matrices. Chondrocytes in Groups B 
 
Figure 4.6 Gross appearance of Group A, B and C implants after 12 weeks implantation (a). 
Representative images of hematoxylin and eosin (HE) staining, alcian blue (Alcian blue) staining and 
immunohistochemical staining of type II collagen (Col-II) of Group A, B and C implants after 12 weeks 
implantation (b). Scale bar: 200 µm. 
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and C had a heterogeneous distribution. Cell density in the micropores was very high while cell density in 
GelMAGMA bulk hydrogel matrices was very low. In particular, in Group C no cells were observed in 
GelMAGMA bulk hydrogel matrices. Alcian blue staining showed that there was abundance of cartilaginous 
matrices in Group A implants. Most of the cartilaginous matrices were detected surrounding the 
chondrocytes. In Group B implants, extracellular matrices in micropores were very positively stained while 
the extracellular matrices in GelMAGMA bulk hydrogel were slightly stained. In Group C implants, only the 
extracellular matrices in micropores were stained by alcian blue. The GelMAGMA bulk hydrogel matrices 
were not positively stained. Immunohistochemical staining of type II collagen showed that type II collagen 
was detected surrounding chondrocytes in Group A, distributing throughout the implant. However, in Group 
B, type II collagen was predominately detected in micropores and slightly in GelMAGMA bulk hydrogel 
matrices. In Group C, type II collagen was only detected in micropores, not in the GelMAGMA bulk 
hydrogel matrices. The immunohistochemical staining results of type II collagen were similar to that of 
alcian blue staining results. The results indicated that cartilaginous matrices were homogeneously distributed 
in hydrogels without microporous structures while predominately distributed in the micropores of 
microporous hydrogels. 
4.4.5 DNA and sGAG quantification and cartilaginous gene expression of in vivo implants 
 
 
Figure 4.7 Quantification of DNA amount (a) and sGAG content (b) in the implants after 12 weeks 
implantation. The data were normalized with dry weight of the hydrogels. sGAG/DNA ratio in each implant 
after 12 weeks implantation (c). Expression of genes encoding collagen type II (d) and aggrecan (e) of P2 
chondrocytes used for cell seeding (0 week) and chondrocytes in the implants after 12 weeks implantation. 
Gene expression data were normalized by using P2 chondrocytes as a reference. Means ± SD, N=3. *, p < 
0.05; **, p < 0.01 and ***, p < 0.001. 
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DNA amount and sGAG content in the implants before implantation and after 12 weeks implantation 
were quantified (Figure 4.7a). After 12 weeks of in vivo implantation, Group B implants had the highest 
DNA amount while Group A implants had the lowest. Compared to the DNA amount before implantation, 
DNA amount in Group A decreased, in Group C kept at the same level while in Group B increased. The 
results indicated that chondrocytes proliferated only in Group B, which might be due to the proliferation of 
migrated chondrocytes in the micropores of Group B. In vitro culture results also indicated that the 
chondrocytes seeded in GelMAGMA bulk hydrogel migrated to the micropores, adhered and spread at the 
micropore interface. The migrated chondrocytes in the micropores in Group B proliferated during in vitro 
culture. Decrease of DNA amount in Group A implants might be due to partial cell death during long period 
implantation. Formation of cartilaginous matrices in the GelMAGMA bulk hydrogel might hamper diffusion 
of nutrients and therefore affect cell proliferation. Chondrocytes in Group C did not proliferate during 
implantation. The porous structures in Group C implants should improve nutrient diffusion that was 
important for chondrocytes proliferation while high cell density in the micropores at the beginning could 
form aggregates and therefore hamper cell proliferation. Cell behaviors in Group C should be the sum of the 
contrary effects of microporous structure and high cell seeding density. 
The sGAG content and sGAG/DNA value in all the groups increased significantly after 12 weeks 
implantation (Figure 4.7b, 4.7c). After 12 weeks implantation, the sGAG content and sGAG/DNA value in 
Group A implants were significantly higher than those in Group B and C implants. The sGAG content and 
sGAG/DNA value in Group B and C were at the same level. The results indicated that gelatin hydrogel 
without microporous structures could promote the production of cartilaginous matrices more strongly than 
did gelatin hydrogels with microporous structures. Gene expression of type II collagen and aggrecan 
indicated that chondrocytes in Group A implants showed the highest expression of these two cartilaginous 
genes (Figure 4.7d and 4.7e). Expression of type II collagen and aggrecan in Group A implants was 
promoted while that in Group B and C did not change or decreased a little. 
The results from both in vitro cell culture and in vivo implantation showed that chondrocytes showed 
different behaviors in Group A, B and C hydrogels. In GelMAGMA hydrogels without microporous 
structures (Group A), chondrocytes were distributed homogeneously in hydrogel matrices, formed small cell 
aggregates and showed high production and expression of cartilaginous matrices without proliferation. On 
the other hand, in GelMAGMA hydrogels with microporous structures (Group B and C), chondrocytes were 
predominantly distributed in the micropores, spread and proliferated with low production and expression of 
cartilaginous matrices. In gelatin hydrogels with microporous structures, cell seeding method also affected 
cell functions. Cell seeded in the bulk hydrogels (Group B) partially migrated in the micropores, adhered and 
spread at the interfaces of micropores and medium. The migrated chondrocytes could proliferate quickly in 
the micropores to fill the spaces and meanwhile to form big cell aggregates. Cell seeding in the micropores 
(Group C) constrained all the chondrocytes in the micropores without migration to bulk hydrogels, which 
resulted in high cell density in the micropores. The high density of chondrocytes in the micropores could 
induce the formation of big cell aggregates with very limited proliferation.[36,37]  
Comparison of gelatin hydrogels with or without microporous structures indicated that culture in gelatin 
hydrogels without microporous structures was favorable for the production of cartilaginous matrices but not 
for cell proliferation, while culture in gelatin hydrogels with microporous structures was beneficial for cell 
proliferation but not for the production of cartilaginous matrices. Gelatin hydrogels without microporous 
structures could provide three-dimensional microenvironments that were similar to the in vivo 
microenvironment which is favorable to cell differentiation. It has been reported that three-dimensional 
microenvironments promote chondrogenic differentiation of stem cells or maintain the chondrogenic 
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morphology of chondrocytes.[18-21] Pore structures in porous sponges or fabric scaffolds have been 
reported to facilitate cell proliferation.[38] The pores in porous sponges or fabric scaffolds should not only 
provide spaces for accommodation, adhesion and proliferation of seeded cells but also provide 
interconnected microporous structures for cell migration and nutrient diffusion in the scaffolds. The 
introduction of microporous structures in hydrogels has been proposed and many microporous hydrogels 
have been reported for tissue engineering of a variety of tissues. However, cell proliferation in microporous 
hydrogels is slower than that in porous sponges or fabric scaffolds, which should be due to the difference of 
pore interconnectivity.[8] Pore interconnectivity should be considered to further improve the functions of 
microporous hydrogels for tissue engineering applications. 
4.5 Conclusions 
Chondrocyte-laden gelatin hydrogels with or without microporous structures were prepared with 
photocrosslinkable gelatin methacrylate macromer and gelatin microgels. The gelatin microgels with 
microcubic shapes were dissolved to form micropores in the hydrogels during cell culture. Chondrocytes 
were encapsulated in the gelatin bulk hydrogels or released from the micropore-forming gelatin microgels. 
Effects of microporous structures on the proliferation and differentiation of chondrocytes were disclosed. 
Chondrocytes migrated from gelatin bulk hydrogels to the micropores while not from the micropores to the 
bulk hydrogels. Gelatin hydrogels without microporous structures promoted expression and production of 
cartilaginous matrices while hampered cell proliferation. Gelatin hydrogels with microporous structures were 
beneficial for cell proliferation while had not evident effect on the expression and production of cartilaginous 
matrices. Gelatin hydrogels with different microporous structures showed different effects on chondrocyte 
functions. The results should provide useful information for preparation of scaffolds for tissue engineering.   
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5.1 Concluding remarks  
 
 
This study focused on the fabrication of photocrosslinkable gelatin hydrogels with different stiffness 
and microporous structures for cartilage tissue engineering. Firstly, the GelMA hydrogels with different 
stiffness were synthesized and studied for 3D culture of chondrocytes. Secondly, the highly crosslinked 
GelMAGMA hydrogel was fabricated with double methacrylate modified gelatin macromer to investigate 
the influence of crosslinking density on chondrocyte proliferation and phenotype. Finally, the microporous 
gelatin hydrogels were fabricated to study the effect of microporous structure on chondrocyte functions. 
 
Chapter 1 introduces the background of conventional treatments of cartilage defect and cartilage tissue 
engineering. The factors and problems in cartilage tissue engineering are also reviewed. Various kinds of 
scaffolds, such as porous scaffolds, fabric scaffolds and hydrogels are compared. Furthermore, the 
advantages of photocrosslinkable gelatin hydrogel are discussed and the reasons to choose gelatin hydrogels 
with different stiffness and microporous structures are explained. 
 
Chapter 2 describes the fabrication of GelMA hydrogels with different stiffness by using the macromers 
with different functionalization degree. In this part, the same concentration of gelatin macromer was used to 
prepare the gelatin hydrogels to exclude the effect of biochemical influence, such as RGD density. 
Chondrocytes were encapsulated in the hydrogels for 3D culture. The results of chondrocyte morphology, 
chondrogenic matrices secretion and chondrogenic gene expression demonstrated that gelatin hydrogels with 
higher stiffness were beneficial for the maintenance of chondrogenic phenotype. 
 
Chapter 3 presents a novel method to synthesize the double methacrylate modified gelatin macromer 
GelMAGMA. The GelMAGMA hydrogels exhibited a high storage modulus and a slow enzymatic 
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degradation. Chondrocytes cultured in the GelMA and GelMAGMA hydrogels showed high cell viability. 
Chondrocytes in the gelatin hydrogels had round morphology and maintained cartilaginous phenotype while 
the secretion of ECM and chondrogenic phenotype was a little inhibited by highly crosslinked GelMAGMA 
hydrogel. The GelMAGMA hydrogel should be useful for strengthening hydrogel scaffolds with a low 
degradation rate for cartilage tissue engineering.  
 
Chapter 4 describes the effect of microporous structures in gelatin hydrogels on chondrocyte functions. 
A cutting method was used to prepare gelatin hydrogel microcubes as porogen materials to introduce 
microporous structures in hydrogels. The combination of the microcubes and photocrosslinkable 
GelMAGMA hydrogel was used to prepare the microporous GelMAGMA hydrogels. The microporous 
hydrogels were used for 3D culture of chondrocytes. The results indicated that chondrocytes cultured in the 
microporous hydrogels showed higher proliferation while lower expression and production of cartilaginous 
matrices. Chondrocytes cultured in gelatin hydrogels without microporous structures showed high expression 
and production of cartilaginous matrices while low cell proliferation. Gelatin hydrogels with or without 
microporous structures showed different effects on chondrocytes functions.  
 
In conclusion, photocrosslinkable gelatin hydrogels with different stiffness, crosslinking density and 
microporous structures were prepared for 3D culture of chondrocytes. Gelatin hydrogels could mimic the in 
vivo ECM environment and possess a good biocompatibility. GelMA hydrogels with different stiffness could 
be fabricated by altering the modification degree of GelMA macromers while keeping the same mass 
concentration. Double modified gelatin macromer (GelMAGMA) was synthesized by further binding the 
hydroxyl and carboxyl groups in gelatin molecules with glycidyl methacrylate to increase the 
photocrosslinkable double bonds in gelatin macromers. The highly crosslinked gelatin hydrogels improved 
mechanical properties and degradation rate of gelatin hydrogels. Furthermore, gelatin hydrogels with 
microporous structures were fabricated by mixing with gelatin hydrogel microcubes. The microporous 
gelatin hydrogels could promote the proliferation of encapsulated cells. The results of this study should 
provide some valuable information for the design and preparation of hydrogels for cartilage tissue 
engineering. 
 
5.2 Future prospects 
 
The study described in this dissertation was focused on the synthesis of photocrosslinkable gelatin 
macromers and fabrication of gelatin hydrogels with different mechanical properties or microstructures. All 
the conclusions obtained from this study are useful to the future design of gelatin-based hydrogels for 
cartilage tissue engineering and clinical applications. 
 
In this study, the isolated bovine articular chondrocytes were used for cartilage tissue regeneration. 
However, it is difficult to get a sufficient number of functional chondrocytes from elderly patients with 
osteoarthritis. Furthermore, during 2D expansion culture, chondrocytes lose the chondrogenic phenotype. In 
the future work, other cell sources, such as stem cells should also be used for 3D culture in the 
photocrosslinkable hydrogels because stem cells can be derived from bone marrow or other tissues. After 
getting enough cell number by subculture, stem cells can be encapsulated in the gelatin hydrogels for 3D 
cultivation.  
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The microporous hydrogel fabricated in this study can also be used for coculture. Many literatures have 
reported that coculture of chondrocyte and stem cell can be used for cartilage regeneration. A small number 
of chondrocytes may produce some chondrogenic induction factors and promote chondrogenic 
differentiation of stem cells. At the same time, stem cells can secret some growth factors to promote the 
proliferation of chondrocytes. Therefore, the GelMAGMA hydrogels may be useful for the coculture of 
chondrocytes and stem cells. Because these materials and systems are biocompatible and injectable, they 
may also be used for tissue engineering of other tissues and organs.
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